Advanced Practices in Quality Management & Patient Safety
Advanced Practices in Quality Management & Patient Safety is designed to enhance the quality skills of healthcare professionals. This online program features a curriculum grounded in evidence-based standards and leading practices in quality, safety, and improvement, all delivered by expert JCI faculty.
After completing this program, you will be able to:
• Design a Quality Program
• Reduce Risk of Harm to Patients
• Lead Improvement Projects
Program Schedule
10 Weeks
40-hours total
• Manage Data
• Build on Accreditation to Improve Quality
Learning
of computer-based learning modules, readings, exercises and knowledge checks
To register, please scan the QR code.
HEALTH AND WELLNESS TOURISM... BROADER SERVICES AND NEW LEADING DESTINATIONS
The medical tourism industry is growing rapidly, making these services available for a wide range of treatments, destinations, and times.
This sector has become very active, with both governments and private sectors focusing on investing in it. Medical sciences are rapidly advancing, and countries and wellness destinations are strongly entering the competition, striving to provide high-quality wellness services. The medical tourism sector was severely affected during the COVID-19 pandemic.
The sector experienced damage from multiple fronts. Tourism and travel across countries were disrupted to prevent the spread of infection to and from travelers. Hospitals worldwide became overwhelmed with COVID-19 patients, and medical staff were fully devoted to treating the infected. They often operated with less than half of their workforce, as the pandemic sidelined the other half.
More than two years after the pandemic's decline, the wellness tourism sector has made a strong recovery. Its global annual value is now $651 billion, and the average annual growth rate of expenditure is expected to be 16.6% until 2027. This sector not only provides sustainable benefits to global, regional, and local economies but also contributes to improving the physical and mental health and psychological well-being of visitors.
In the midst of this renaissance, there were countries globally known as successful destinations for wellness tourism, and the Middle East was among the most attractive destinations for health and relaxation seekers. As this activity has expanded globally, new countries have entered the competition, proving their worth in this field. This has heralded a more pioneering wellness sector with more expansive and high-quality health services for travelers seeking treatment, comfort, and tranquility!
The Publisher
Publisher Arab Health Media Communication
President Simon Chammas schammas@tahmag.com
Executive Vice President Mirna Khairallah mirna@tahmag.com
All rights reserved by the HOSPITALS magazine. No part of this publication can be reproduced in any form without prior permission in writting from the publisher.
22
Becton Dickinson Revolutionizing Efficiency with Laboratory Automation
80 ACIBADEM INTERNATIONAL Physician-Robot cooperation yields big gains!
102 Cedars-Sinai Secures Global Healthcare Accreditation for a Second Time
Enhancing Safety and Hygiene: Modern Practices in Hospital Cleanliness and Food Safety
NEWS
8 Dr. Neelam Dhingra, a leading global patient safety expert, to lead JCI’s patient safety and quality improvement efforts
14 Cinfa launches Rosvacor in Qatar, offering an effective solution for the treatment of cardiovascular diaseases
56 Asan – UAE Gastroenterology Hospital in Dubai Healthcare City Phase 2 represents a milestone in the advancement of Dubai’s healthcare offerings
ARTICLES
10 KFSHRC - Redefining Cardiac Care: The Path to Advanced Mechanical Circulatory Support
16 Baylor St. Luke’s Medical Center: The Texas Heart Institute Implants BiVACOR® Total Artificial Heart
90 Al-Ahli Hospital Qatar: Unveiling the World of Plastic Surgery Reversal: Restoring Confidence and Identity
96 Al-Ahli Hospital Qatar: Transform Your Smile: The Importance of Cosmetic Dental Treatment
106 An AI-Driven Dream: Towards Emirates Health Service's Vision of Sustainable Healthcare/ Her Excellency Mubaraka Ibrahim - Acting CIO, Emirates Health Services Mr. Sooraj Pilankuveedu - Director, Oracle Health
112 Advancing Fertility Solutions, The Role of IVF at Al-Ahli Hospital Qatar
Confronting Depression: A Journey Towards Restoring Hope and Mental Health
Medicine, Division of Hematology and Oncology, Weill Cornell Medicine, New York - Assistant Attending Physician, NewYork-Presbyterian Hospital, Visiting Faculty Member, Weill Cornell Medicine-Qatar
70 Dr. Ghida Mouharram Choureiki, Head of Diagnostic Imaging / Radiology at Unit Clemenceau Medical Center, Beirut-Lebanon
92 Dr. Mohamad Kodeih, Plastic and Reconstructive Surgeon
FEATURES
62 Cervicitis
67 Polycystic Ovary Syndrome
74 Enhancing Safety and Hygiene
108 Women's Wellness: Addressing the Epidemic of Anxiety and Stress
114 Confronting Depression: A Journey Towards Restoring Hope and Mental Health
MEDICAL INSTITUTIONS
80 ACIBADEM: robotic era in organ transplantation!
84 UChicago Medicine among the first in the country to offer newly approved sickle cell gene therapies
86 Obesity: Surgery and Treatment Options at Acıbadem Healthcare Group
98 ACIBADEM: Badem Pediatrics Oncology Center
102 Cedars-Sinai Secures Global Healthcare Accreditation for a Second Time
104 Liv Hospital: Digital transformation in health
Dr. Neelam Dhingra, a leading global patient safety expert, to lead JCI’s patient safety and quality improvement efforts
Joint Commission International (JCI) announced the appointment of Neelam Dhingra, MBBS, MD, as its new Vice President and Chief Patient Safety Officer, effective 1 June 2024. Dr. Dhingra, a leading global patient safety expert, previously led the World Health Organization’s (WHO) programs on patient safety and blood safety for more than two decades.
Most recently, Dr. Dhingra was Unit Head for the Patient Safety Flagship at WHO. Under her leadership in this role, several key milestones were achieved including the World Health Assembly resolution ‘Global Action on Patient Safety’, ‘Global Patient Safety Action Plan 2021-2030’, World Patient Safety Day, Global Patient Safety Network, Global Patient Safety Report 2024 and more.
ernmental, non-governmental, and healthcare organizations and systems. She will be based in Geneva, Switzerland.
AS JCI VICE PRESIDENT AND CHIEF PATIENT SAFETY OFFICER, DR. DHINGRA WILL PROVIDE STRATEGIC LEADERSHIP ON PATIENT SAFETY AND PROMOTE ALL ASPECTS OF JCI’S PATIENT SAFETY AND QUALITY IMPROVEMENT ACTIVITIES INTERNATIONALLY. DR. DHINGRA WILL ALSO SERVE AS THE CHIEF SPOKESPERSON ON PATIENT SAFETY AND QUALITY TOPICS EXTERNALLY AT INTERNATIONAL CONFERENCES AND EVENTS.
“A leader and champion for patient safety, Neelam’s work at the World Health Organization helped contribute to our vision of a world in which no one is harmed in healthcare,” adds Sir Liam Donaldson, WHO DG Special Envoy for Patient Safety. “I worked closely with Neelam throughout her time at the World Health Organization. Her passion for patient safety will help to create substantial beneficial change in her new post. I wish her all the very best as she works in this new leadership role to advance patient safety and quality of care for all patients and their families.
As JCI Vice President and Chief Patient Safety Officer, Dr. Dhingra will provide strategic leadership on patient safety and promote all aspects of JCI’s patient safety and quality improvement activities internationally. Dr. Dhingra will also serve as the chief spokesperson on patient safety and quality topics externally at international conferences and events. Additionally, Dr. Dhingra will serve as the key liaison between JCI and the healthcare safety community, including Ministries of Health, inter-gov-
“We are thrilled to welcome Neelam to Joint Commission International to help improve patient safety and quality of care in healthcare organizations around the globe,” says Jonathan B. Perlin, MD, PhD, President and Chief Executive Officer, The Joint Commission and JCI. “As a recognized leader and passionate advocate, Neelam has galvanized global patient safety and quality improvement efforts. I have every confidence that she will help Joint Commission International foster partnerships and advance our global mission to improve patient safety and quality of care for all patients.”
“Neelam will bring invaluable experience and knowledge to Joint Commission International as a patient safety, quality improvement and risk management expert,” adds Abdulelah M. Alhawsawi, MD, FRCS, DABS, Board of Director, JCI, and Chief Executive Officer, Novo Genomics, Riyadh, Saudi Arabia. “Joint Commission International looks forward to Neelam’s leadership as we work with healthcare organizations and other stakeholders around the globe to continuously improve and implement best practices.”
Dr. Dhingra completed her Bachelor of Medicine and Bachelor of Surgery (MBBS) from Lady Hardinge Medical College, New Delhi, India. She earned her Doctor of Medicine in pathology from the All India Institute of Medical Sciences, New Delhi, India, along with advanced training fellowships in the United Kingdom.
Dr. Neelam Dhingra
Redefining Cardiac Care: The Path to Advanced Mechanical Circulatory Support
Dr. Feras Khaliel,
Head of the Section of Cardiac Surgery and the Director of the Robotics and Minimally Invasive Surgery Program at King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh / Professor of Surgery at Alfaisal University
Heart failure continues to be one of the most challenging conditions faced in modern medicine, affecting about 64 million people globally. Traditional treatments, while beneficial, often fail to provide long-term solutions for patients with severe cardiac conditions, highlighting the growing need for innovative approaches.
When it comes to people’s well-being, innovation is not optional—it's essential. Today, healthcare professionals worldwide are pushing the boundaries of cardiac care to offer new hope to those battling heart failure.
As the Head of the Cardiac Surgery section and the Director of the Robotics and Heart Transplant Surgical Program at King Faisal Specialist Hospital & Research Centre (KFSHRC), I am proud of the advancements the Kingdom of Saudi Arabia has achieved in mechanical circulatory support (MCS) systems. These technologies are revolutionizing the treatment of heart and respiratory failure.
To better appreciate the innovations that have transformed cardiac patient care and anticipate future breakthroughs that will improve patient outcomes, here’s a quick recap of the evolution of MCS systems.
For many years, the Extracorporeal Membrane Oxygenation (ECMO) provided support for severe heart and lung failure. While ECMO's life-saving capabilities are typically temporary, Ventricular Assist Devices (VADs) have revolutionized long-term care by helping the heart pump blood, serving as either a bridge to transplantation or a permanent solution for patients ineligible for transplants. Modern VADs have dramatically improved patients' quality of life. For severe biventricular heart failure, the Total Artificial Heart (TAH) replaces the heart entirely, while other devices offer temporary support during high-risk procedures.
One of the most exciting developments in MCS is the advent of fully implantable VADs. These devices, which are smaller and more efficient than their predecessors, offer patients greater mobility and freedom. As we continue to refine these technologies, we anticipate a future where VADs become a routine treatment option for heart failure patients, providing them with a durable and effective means of support.
I AM PROUD OF THE ADVANCEMENTS THE KINGDOM OF SAUDI ARABIA HAS ACHIEVED IN MECHANICAL CIRCULATORY SUPPORT (MCS) SYSTEMS. THESE TECHNOLOGIES ARE REVOLUTIONIZING THE TREATMENT OF HEART AND RESPIRATORY FAILURE.
KFSHRC is currently the highest-volume centre for MCS, with an average of 70 ECMO, 30 non-durable VADs, and 22 durable VADs per year, and is increasingly integrating robotic technology into cardiac procedures. The precision and efficiency of robotic-assisted VAD implantation have reduced recovery times by up to 30% and improved surgical precision. From 2013 to 2019, the implementation of a multidisciplinary heart team improved 1-year LVAD survival rates to 70%. The HeartMate 3 LVAD further enhanced 1-year survival rates to 75%, with morbidity rates similar to those in clinical trials.
Looking forward, the integration of artificial intelligence (AI) and machine learning into MCS systems is highly promising for improving cardiac patient outcomes. These technologies can help predict complications, optimize device settings, and personalize treatment plans based on realtime data. By harnessing the power of AI, we can enhance the precision and efficacy of MCS. Furthermore, the development of biocompatible materials and improved bioengineering techniques will play a pivotal role in the future of MCS. These advancements will reduce the risk of infection and thrombosis, making MCS devices safer and more reliable. As these materials evolve, they will enable the creation of next-generation devices that are both highly effective and minimally invasive. The future of MCS systems holds immense
potential, presenting radical advancements that offer renewed hope for patients and signify a remarkable progression in cardiac care. It is our collective responsibility to push the boundaries of what is possible, to strive for excellence in developing and implementing these lifesaving devices, and to ensure that every patient benefits from them. Together, let us embrace this challenge, commit to continuous improvement in MCS systems, and lead the way in shaping the future of cardiac healthcare.
About Dr. Feras Khaliel
Dr. Khaliel has profound expertise in heart failure management, specializing in heart transplantation, ventricular assist devices (VADs), and pulmonary thromboendarterectomy (PTE) procedures. Under his leadership, KFSHRC's robotic program has distinguished itself as the only intracardiac surgical program in the Middle East. It is recognized among the top five globally for complex robotic multivalve surgery. A prolific speaker and author, Dr. Khaliel has delivered presentations at over 200 medical congresses and published more than 30 scientific papers.
LOOKING FORWARD, THE INTEGRATION OF ARTIFICIAL INTELLIGENCE (AI) AND MACHINE LEARNING INTO MCS SYSTEMS IS HIGHLY PROMISING FOR IMPROVING CARDIAC PATIENT OUTCOMES. THESE TECHNOLOGIES CAN HELP PREDICT COMPLICATIONS, OPTIMIZE DEVICE SETTINGS, AND PERSONALIZE TREATMENT PLANS BASED ON REALTIME DATA. BY HARNESSING THE POWER OF AI, WE CAN ENHANCE THE PRECISION AND EFFICACY OF MCS.
Finalists announced for IHF Awards 2024
The International Hospital Federation (IHF) has announced the finalists of the IHF Awards 2024 after the judges completed scoring entries in all 7 Award categories.
IHF Awards shortlists 49 finalists
The IHF Awards 2024 received more than 500 entries by hospitals and healthcare organizations from 37 countries and territories competing for the following Awards:
• Dr Kwang Tae Kim Grand Hospital Award – recognizing hospitals that excelled in the five dimensions of healthcare delivery: quality and safety, patient experience, cost efficiency, workforce wellbeing, and health equity and access.
• Dr Prathap C Reddy Excellence Award for Clinical Quality and Patient Safety – a new Award for 2024 – honoring hospitals for their innovative and exemplary projects or programs in enhancing clinical quality and patient safety.
• American Hospital Association Excellence Award for Healthcare Workers’ Wellbeing – recognizing excellence or outstanding achievements in ensuring the wellbeing and sustainability of healthcare workers.
• Mastercard Award for Hospital Operational Excellence – a new Award for 2024 – acknowledging measurable success in operational outcomes and efficiencies through projects, programs, or services.
• American College of Healthcare Executives Excellence Award for Leadership and Management – honoring excellence or outstanding leadership and management in hospitals or healthcare organizations.
• Ashikaga-Nikken Excellence Award for Low-Carbon Healthcare – recognizing impactful approaches to promoting sustainable healthcare, reducing carbon emissions, enhancing environmental responsibility, and contributing positively to the wellbeing of patients,
Out of more than 500 entries this year, a total of 49 finalists have been shortlisted for the 7 contested IHF Awards, from which the Gold, Silver, and Bronze Awards, as well as honorable mentions, will be selected and presented in each category. The shortlisted projects and program in each category represent the innovation, good practice, and service improvement transforming the healthcare sector in IHF Member organizations across the globe. The IHF Awards recognize and amplify exemplary work that improves the level, standard, quality, operational efficiency and sustainability of healthcare service delivery. This annual showcase of excellence in hospital leadership and management is one of the core programs by which the IHF fulfils its commitment to promoting international knowledge sharing and exchange.
staff and community.
• Seddiqi Holding Excellence Award for Social and Environmental Responsibility – acknowledging excellence or outstanding achievements in advancing corporate social responsibility.
The judging process involved an extensive review by members of the Awards Committee, comprising 44 healthcare leaders and senior executives from around the world. The scoring for the 6 Excellence Awards is based on five criteria: originality and innovation; intended impact; adaptability and scalability; scientific rigor; and clarity. For the Grand Hospital Award, entries were scored based on overall success in achieving the five dimensions of healthcare delivery (health service quality, patient experience, clinical outcomes and health equity, cost efficiency, and workforce wellbeing), as well as ability to sustain their success, and achievements.
Dr Lawrence Lai, Chair of the IHF Awards Committee, shared his impression of this year’s submissions: “Since its inception in 2015, I cannot help but be impressed by the increasing number of high-quality entries to the IHF Awards in each successive year – and 2024 is no exception. This global platform enables the IHF to spotlight innovative or outstanding projects that are making a real impact on healthcare delivery, clinical quality and patient safety. The learning from these Award-winning entries resonates with hospital leaders worldwide, inspiring future excellence and achievement that will, in turn, advance our health services and bring benefits to the communities which we serve. On behalf of the Awards Committee, I would like to sincerely thank all of the hospitals and healthcare organizations for their enthusiastic participation in the Awards program this year. I would also like to take this opportunity to express my gratitude to all the sponsors for making the Awards possible, and members of the Awards Committee for their dedication and meticulous work in scoring entries and selecting this year’s very worthy IHF Awards recipients.”
Cinfa launches Rosvacor in Qatar, offering an effective solution for the treatment of cardiovascular diaseases
The European pharmaceutical laboratory
Cinfa has launched its new product Rosvacor (Rosuvastatin) in Qatar. This marks an important milestone in Cinfa's expansion in the cardiometabolic area, offering new therapeutic options for dyslipidemia and prevention of cardiovascular diseases. Rosvacor is available in doses of 5mg, 10mg, and 20mg.
Cinfa has carried out this launch in response to the increasing prevalence of dyslipidemia and cardiovascular events in the Middle East, a region where these diseases represent a significant public health challenge. Dyslipidemia is a major risk factor for atherosclerotic cardiovascular disease (ACD), which includes ischemic heart disease (IHD) and strokes. In the UAE, IHD and strokes are leading causes of premature death, responsible for approximately 40% of all deaths in the country. Effective management of dyslipidemia is crucial, as it can significantly reduce the progression of atherosclerosis and associated cardiovascular diseases. Rosuvastatin, the key molecule in the treatment of dyslipidemia, has been shown to be effective in reducing LDL cholesterol, thus contributing to the prevention of cardiovascular diseases. According to the WHO, a 10% reduction in serum cholesterol levels can halve the risk of IHD in 40-year-old men over five years, underscoring the importance of medications like Rosvacor in managing dyslipidemia.
Hydrochlorothiazide)
• Olmedine (Olmesartan Amlodipine)
• Zetmol (Ezetimibe)
Strengthening the Cardiometabolic Portfolio
The addition of Rosvacor expands Cinfa's cardiometabolic portfolio in Qatar, which already includes the following medicines:
• Atorcor (Atorvastatin)
• Vanguard (Valsartan)
• Vanguard Plus (Valsartan Hydrochlorothiazide)
• Olmepress (Olmesartan)
• Co-Olmepress (Olmesartan
Cinfa's strategy in the region focuses on addressing the alarming rise in diseases such as diabetes, hypertension, and other cardiovascular disorders, both in the Western and Eastern worlds. Franc Vives, Chief International Officer at Cinfa, has emphasized the importance of focusing on these areas to provide effective solutions to patients, and has stated, "everything related to ischemic heart disease treatment, diabetes, hypertension, among others, constitutes the core of our strategy in the region". And has added that “this approach is clearly reflected in the launch of Rosvacor and the ongoing expansion of our cardiometabolic product portfolio in Qatar. According to our mission of improving the health and well-being of patients in Qatar and beyond, always focused on high-quality, safe and effective medicines and health solutions.”
1 Roadmap for the Management of Type 2 Diabetes and Hypertension in the Middle East: Review of the 2022 EVIDENT Summit. https://link.springer.com/article/10.1007/s12325-02302529-7
2 Dyslipidemia prevalence and associated risk factors in the United Arab Emirates: a population-based study. https://bmjopen. bmj.com/content/9/11/e031969
CINFA INTRODUCES ROSVACOR (ROSUVASTATIN) TO THE QATARI MARKET, PROVIDING A TREATMENT FOR DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASES. DYSLIPIDEMIA AND CARDIOVASCULAR DISEASES ARE SIGNIFICANT HEALTH CHALLENGES IN THE MIDDLE EAST, WITH DYSLIPIDEMIA ALONE RESPONSIBLE FOR APPROXIMATELY 40% OF ALL DEATHS IN THE UAE1,2
Cancer treatment plans built around you.
Our experts get to know you, then tailor treatments to help fit your needs—which could include radiation, surgery, chemotherapy, immunotherapy, cellular therapy, genetic counseling, or a customized lifestyle management plan. In collaboration with Baylor College of Medicine, we’re equipped to pave the way for even more revolutionary discoveries and groundbreaking approaches to cancer prevention, diagnosis, and treatment.
Learn more about the NCI-designated Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine at stlukeshealth.org/bslmcinternational
Baylor St. Luke’s Medical Center
The Texas Heart Institute Implants BiVACOR® Total Artificial Heart
Baylor St. Luke’s Medical Center, part of CommonSpirit Health, is home to the successful first-in-human implantation of the BiVACOR Total Artificial Heart (TAH) as part of the U.S. Food and Drug Administration (FDA) Early Feasibility Study (EFS), The Texas Heart Institute (THI) and BiVACOR® announced.
BiVACOR’s TAH is a titanium-constructed, biventricular rotary blood pump with a single moving part that utilizes a magnetically levitated rotor that pumps the blood and replaces both ventricles of a failing heart. The implantation occurred on July 9, 2024.
The first-in-human clinical study aims to evaluate the safety and performance of the BiVACOR TAH as a bridge-to-transplant solution for patients with severe biventricular heart failure or univentricular heart failure in which left ventricular assist device support is not recommended. Following this first implantation completed at Baylor St. Luke’s Medical Center in the Texas Medical Center, four additional patients are to be enrolled in the study.
“It takes unmatched research, innovation and excellence to advance cardiovascular care continuously,” said Brad Lembcke, MD, President of Baylor St. Luke’s Medical Center. “The BiVACOR Total Artificial Heart represents another historic milestone with Baylor St. Luke’s, The Texas Heart Institute, and Baylor College of Medicine in the Texas Medical Center. Together, we are ushering in a new era of hope for patients with end-stage heart failure.”
“The Texas Heart Institute is enthused about the groundbreaking first implantation of BiVACOR’s TAH. With heart failure remaining a leading cause of mortality globally, the BiVACOR TAH offers a beacon of hope for countless patients awaiting a heart transplant,” said Dr. Joseph Rogers, President and Chief Executive Officer of The Texas Heart Institute and
National Principal Investigator on the research.
“We are proud to be at the forefront of this medical breakthrough, working alongside the dedicated teams at BiVACOR, Baylor College of Medicine, and Baylor St. Luke’s Medical Center to transform the future of heart failure therapy for this vulnerable population.”
Daniel Timms, PhD, Founder and Chief Technology Officer of BiVACOR said, “I’m incredibly proud to witness the successful firstin-human implant of our TAH. This achievement would not have been possible without the courage of our first patient and their family, the dedication of our team, and our expert collaborators at The Texas Heart Institute. Utilizing advanced MAGLEV technology, our TAH brings us one step closer to providing a desperately needed option for people with endstage heart failure who require support while waiting for a heart transplant. I look forward to continuing the next phase of our clinical trial.”
HEART FAILURE IS A GLOBAL EPIDEMIC AFFECTING AT LEAST 26 MILLION PEOPLE WORLDWIDE, 6.2 MILLION ADULTS IN THE U.S., AND IS INCREASING IN PREVALENCE. HEART TRANSPLANTATIONS ARE RESERVED FOR THOSE WITH SEVERE HEART FAILURE AND ARE LIMITED TO FEWER THAN 6,000 PROCEDURES PER YEAR GLOBALLY.
Heart failure is a global epidemic affecting at least 26 million people worldwide, 6.2 million adults in the U.S., and is increasing in prevalence. Heart transplantations are reserved for those with severe heart failure and are limited to fewer than 6,000 procedures per year globally. Consequently, the U.S. National Institutes of Health estimated that up to 100,000 patients could immediately benefit from mechanical circulatory support (MCS), and the European market is similarly sized.
The successful implantation of BiVACOR’s TAH highlights the potential of innovative technologies to address critical challenges in cardiac care, such as long transplantation waitlists. BiVACOR and The Texas Heart Institute remain committed to advancing the field of cardiac medicine and improving outcomes for patients worldwide.
BiVACOR Total Artificial Heart
The BiVACOR TAH represents a paradigm shift in artificial heart design. The size of the BiVACOR TAH is suitable for most men and women (Body Surface Area >1.4 m2).
Despite its small size, the BiVACOR TAH is
capable of providing enough cardiac output for an adult male undergoing exercise. Using magnetic levitation technology, the same principle used in high-speed trains, the product features a unique pump design with a single moving part: a magnetically suspended dualsided rotor with left and right vanes positioned within two separate pump chambers, forming a double-sided centrifugal impeller that propels blood from the respective pump chambers to the pulmonary (lung) and systemic (body) circulations. The TAH has no valves or flexing ventricle chambers, with MAGLEV making pulsatile outflow possible by rapidly cycling the pump's rotor. The non-contact suspension of the rotor via MAGLEV is designed to eliminate the potential for mechanical wear and provide large blood gaps that minimize blood trauma, offering a durable, reliable, and biocompatible heart replacement.
THE SUCCESSFUL IMPLANTATION OF BIVACOR’S TAH HIGHLIGHTS THE POTENTIAL OF INNOVATIVE TECHNOLOGIES TO ADDRESS CRITICAL CHALLENGES IN CARDIAC CARE, SUCH AS LONG TRANSPLANTATION WAITLISTS. BIVACOR AND THE TEXAS HEART INSTITUTE REMAIN COMMITTED TO ADVANCING THE FIELD OF CARDIAC MEDICINE AND IMPROVING OUTCOMES FOR PATIENTS WORLDWIDE.
Bangkok Hospital Invests in State-of-the-Art Robot-Assisted Surgery to Elevate Patient Care through Surgical Innovation
Bangkok Hospital, a leading healthcare provider in Thailand, has invested over 200 million Baht to establish a cutting-edge robotic surgery center. The facility is equipped with multiple operating rooms integrated with the latest robotic platforms, including the da Vinci Xi Surgical System. This investment underscores the hospital's commitment to becoming the premier destination for robotic-assisted surgery in Southeast Asia.
Having successfully completed 200 cases, Bangkok Hospital showcases its expertise in leveraging state-of-the-art technology to deliver superior patient outcomes. The hospital's strategic vision is to become the robotic hub of Southeast Asia, making advanced surgical treatments more accessible to patients throughout the region at competitive prices.
The da Vinci Xi Surgical System enables surgeons to perform complex procedures with improved precision and better dexterity. Conditions that can benefit from robot-assisted surgery include thoracic diseases like lung cancer; urological diseases such as prostate and kidney cancers; abdominal and hepato-pancreato-biliary diseases including hernias and liver cancer; as well as gynecological diseases like uterine fibroid and ovarian mass.
"We are dedicated to addressing the unique healthcare challenges faced by Southeast Asia, including the growing burden of cancers, an aging population, and disparities in access to quality care," said Dr. Ekkit Surakarn, Deputy Hospital Director of Bangkok Hospital. "Our robot-assisted surgery program is centered around delivering tangible benefits and value to our patients, while actively engaging with insurance providers to expand coverage for these advanced treatments."
The hospital has achieved remarkable outcomes, with significant improvements in key operating indicators such as reduced blood loss,
shorter recovery time, faster patient mobilization, decreased risk of infection, and unplanned readmission. In specific procedures, the use of robotic systems has enabled nerve-sparing techniques while preserving urinary function in prostate cancer cases and improved lymph node removal in lung cancer cases.
Bangkok Hospital's multidisciplinary approach brings together highly skilled medical teams to create personalized treatment plans and deliver comprehensive care throughout the patient's journey.
The hospital's 5-year roadmap includes expanding its robotic surgery capabilities, covering more specialties such as ear-nose-throat surgery while investing in education and training to establish Bangkok Hospital as a regional center for skill development.
"We remain dedicated to advancing the frontiers of robotic surgery and expanding its benefits to patients across Asia," stated Dr. Ekkit Surakarn.
For more information about Bangkok Hospital's Robotic Surgery Institute, please visit: https://www.bangkokhospital.com/en/ campaign/robotic-surgery
HAVING SUCCESSFULLY COMPLETED 200 CASES, BANGKOK HOSPITAL SHOWCASES ITS EXPERTISE IN LEVERAGING STATE-OF-THE-ART TECHNOLOGY TO DELIVER SUPERIOR PATIENT OUTCOMES. THE HOSPITAL'S STRATEGIC VISION IS TO BECOME THE ROBOTIC HUB OF SOUTHEAST ASIA, MAKING ADVANCED SURGICAL TREATMENTS MORE ACCESSIBLE TO PATIENTS THROUGHOUT THE REGION AT COMPETITIVE PRICES.
WCM-Q alumni receive inaugural Qatar Medical Specialization Certificate
Three alumni from Weill Cornell Medicine-Qatar (WCM-Q) were among the inaugural cohort of 36 physicians to receive the prestigious Qatar Medical Specialization Certificate from the Qatar Board of Medical Specialties (QBMS). The certification marks a significant milestone in enhancing medical proficiency in Qatar.
Dr. Navid Iqbal (Class of 2016), an Emergency Medicine Resident at Hamad Medical Corporation (HMC), and two graduates from the Class of 2019—Dr. Angela Dandan, a Fellow Psychiatrist at HMC, and Dr. Sahar Mahadik, a Resident Anesthesiologist at HMC—were among those who received the certificates.
The certificates were awarded during a ceremony attended by prominent healthcare officials, including the Minister of Public Health, HE Dr. Hanan Al Kuwari, Dr. Saad Al Kaabi, director of the Department of Healthcare Professions at the Ministry of Public Health, and HE Dr. Hajar Ahmed Hajar Al Binali, former Minister of Public Health, along with other senior healthcare figures. To earn the QBMS certificate, trainees must complete a demanding course that lasts
four to six years, depending on their specialty, and successfully pass three examinations. Awardees received certificates in four specialties—family medicine, anesthesia, emergency medicine, and psychiatry.
Dr. Thurayya Arayssi, Vice Dean for Academic and Curricular Affairs at WCM-Q, said: “We are extremely proud of our graduates for earning this demanding certification, which requires many years of dedication. This accomplishment demonstrates the exceptional training they received at HMC, preparing them to meet high standard in their respective medical specialties and showcasing their capability to provide the highest quality medical care. We wish them the best of luck and look forward to their continued contributions to the medical field and the communities they serve.”
Established in 2020, the QBMS certification adheres to the highest global standards, playing a crucial role in improving the efficiency and standards of medical professionals practicing in Qatar. Physicians in Qatar now have the opportunity to earn two board certifications (Qatari and Arab).
THE CERTIFICATES WERE AWARDED DURING A CEREMONY ATTENDED BY PROMINENT HEALTHCARE OFFICIALS, INCLUDING THE MINISTER OF PUBLIC HEALTH, HE DR. HANAN AL KUWARI, DR. SAAD AL KAABI, DIRECTOR OF THE DEPARTMENT OF HEALTHCARE PROFESSIONS AT THE MINISTRY OF PUBLIC HEALTH, AND HE DR. HAJAR AHMED HAJAR AL BINALI, FORMER MINISTER OF PUBLIC HEALTH, ALONG WITH OTHER SENIOR HEALTHCARE FIGURES.
Left to right, Dr. Angela Dandan, Dr. Sahar Mahadik, Dr. Thurayya Arayssi, Dr. Navid Iqbal
Role of Microbiology Lab Automation in Transforming Hospital
Efficiency and Sustainability: Bridging Global and Regional Experiences for Optimizing Efficiency
Bassem Hamdy. Microbiology PhD, Product Manager for Microbiology & Lab Automation, Becton Dickinson, BD Life Sciences - Integrated Diagnostic Solutions, Middle East & North Africa..
Meshari Alabdullatif. Microbiology & Immunology PhD, Medical Affairs Manager, Becton Dickinson, BD Life Sciences - Integrated Diagnostic Solutions, Saudi Arabia
The clinical microbiology laboratory plays a vital role in any healthcare setting to report timely, accurate and validated results to identify and determine appropriate treatment of various bacterial pathogens based on a variety of tests and processes. These procedures and methods have primarily required human manipulation and intervention, while manual non-value added steps related to specimen transport, manual streaking of agar plates, manual incubation and reading of plates, etc.
Through automating many manual processes in the clinical microbiology lab via; automated labeling and streaking of agar plates, transport to automated incubators, digital reading of plates coupled with web-based informatics access to results. Allows for standardization of sample processing, specimen tracking (chain of custody), workflow monitoring and efficiency data, while focusing on the most critical steps of reviewing and verifying results to transform efficiency and accuracy in the clinical
THE DIAGNOSIS OF INFECTIOUS DISEASES AND THE ROLE OF THE MICROBIOLOGY LABORATORY ARE CRUCIAL COMPLEX AND FASCINATING PROCESS OF CHANGE.
microbiology lab. In alignment with this strategy, BD Kiestra™ Automated Microbiology Systems were initially introduced in Europe and currently operating in many countries globally. While on the regional level, 14 systems in five Gulf countries; four in Saudi Arabia, one in Bahrain, seven in Kuwait, one in United Arab Emirates, and one in Qatar.
Since 2004, a study has substantiated the need for overall efficiency in providing results is now given the same importance as accuracy. This means that laboratories must be able to produce quality results in less time with the capacity to interpret the results clinically. To improve the clinical impact of microbiology results, the new challenge facing the microbiologist has become one of process management instead of pure analysis. A proper project management process designed to improve workflow, reduce analytical time, and provide the same highquality results without losing valuable time treating the patient, has become essential1. The diagnosis of infectious diseases and the role of the microbiology laboratory are crucial complex and fascinating process of change. If managed correctly, this change could have a positive impact on the treatment of infectious diseases both clinically and therapeutically1
Several publications are discussing needs for improving the efficiency for microbiology laboratory, at the University Hospital Campus Bio-Medico of Rome in Italy shared their one year of experience for the laboratory automation and intra-laboratory turnaround time2 (TAT). Stating, TAT represents a key factor influencing patient care2. The delay in urgent exams has been reported to have a major impact on the diagnosis and management of patients and on length of stay in the emergency department3. Laboratory automation has been described as an important means of improving the efficiency of the laboratory and TAT observance2. Therefore, total laboratory automation has a positive impact on the laboratory service and helps to provide mean TAT reduction as well as the percentage of outlier decrease2
In 2015, the Journal of Clinical
Microbiology, which belongs to the American Society for Microbiology (ASM) published a comparison between the automated inoculation systems and manual method. They have found that 3- to 10-fold higher yield of discrete colonies was observed following automated inoculation systems than that with manual inoculation. The inoculation with the InoqulA system allowed them to
FIG 1: Impact of the performance of the different manual (MAN1 and MAN2) and automated inoculation InoqulA (INO1 and INO2) and WASP (WAS1 and WAS2) systems on the time to results and laboratory costs.
(A) One discrete colony was required to perform identification by MALDITOF MS at day 1 post-inoculation. Re-isolation was performed when at least one colony was not obtained, leading to a delayed time to results of 1 working day (ID report at day 2). An additional laboratory cost of 3.3 EUR (3.6 USD) per re-isolation was calculated for each subculture, and the results were extrapolated to 100 samples for clarity.
(B) A minimum number of 6 discrete colonies grown on BBL chromogenic agar was required (i) to perform an ID by MALDI-TOF and (ii) to make a bacterial suspension in 2 ml of saline solution equivalent to a 0.5 McFarland standard turbidity to complete AST at day 1 and to report the results at day 2. Thus, each sample containing <6 colonies needed reisolation, leading to a delayed time to AST results of 1 working day (AST report at day 3). Similar to identification, an additional laboratory cost of 3.3 EUR (3.6 USD) per re-isolation was calculated for each subculture, and the results were extrapolated to 100 samples for simplicity.
obtain significantly more discrete colonies than the WASP system at concentrations of >107 bacteria/ml. The analysis of cloudy urine specimens showed that InoqulA inoculation system provided a statistically significantly higher number of discrete colonies than that with WASP and manual inoculation. Consequently, the automated InoqulA inoculation greatly decreased the requirement for bacterial subculture and thus resulted in a significant reduction in the time to results, laboratory workload, and laboratory costs4 (figure 1).
In 2018, a total of 35,564 microbiological urine cultures with and without incubation and processing with BD Kiestra™ Total Laboratory Automation (TLA) for a 6-month period each retrospectively, the time to report was significantly lower in the TLA processed samples by 1.5 hour in addition to TLA showed enhanced growth of nonclassical and rarely cultured bacteria from urine samples. Especially Enterococci and Grampositive rods were isolated more frequently with TLA in general cultivation does not need special media or conditions but time to inoculation may play a role in these cases, as with TLA the samples are processed faster and continuously throughout the working hours5. The polymicrobial specimens are classically regarded as contaminated by vaginal or periurethral microbiota. Particularly about the growing number of immunocompromised patients or patients with altered urinary tracts, the current diagnostic algorithms may not be adequate as they don’t consider the possibility of polymicrobial urinary tract infection in highly susceptible patients like solid organ/stem cell recipients or patients with special urologic conditions6.
Similarly in 2022, the American Association for Clinical Chemistry published a review addressing the current state of laboratory automation in clinical microbiology laboratory due to increasing pressure to reduce costs while maintaining or improving quality created a demand for automation. At the same time, overall testing volumes have
been increasing 5%–10% every year, driven by an aging population, increased numbers of immunocompromised patients, infection control demands, and the growing challenge resulting from detection of multidrug-resistant microorganisms7
The way to truly capitalize on the value offered by automation is to evaluate every current process and determine whether and how it should change. They concluded that a significant number of prescribing decisions are made based on the results generated by the laboratory and optimization of those results may influence timelier clinical decisions7 Moreover, among participated facilities, annual savings per year ranged from $270,000 to $1,200,0008.
Those new technologies will allow earlier detection of microbial growth, automated detection, and auto release of sterile samples, identification and quantification of bacterial colonies, or even automated reading of antibiotic susceptibility testing disk diffusion assays and thus further decrease TATs and increase productivity9.
BD Kiestra™ Solutions Expanding your laboratory’s capabilities. Does your laboratory experience challenges such as?
• Increasing sample volumes and staffing shortages.
• Financial pressures from reduced budgets and smaller reimbursements.
• Resistant organisms demanding accurate detection.
• Lack of access to relevant data for simplified workflow management, analytics, and instrument integration.
When hospitals and health systems evaluate automation platforms, they must recognize the potential impact these technologies have on the capacity of microbiology lab operations. Automation provides laboratories with an opportunity to do things in ways that were previously impossible and to address the challenges of today while preparing for the future.
IN 2018, A TOTAL OF 35,564 MICROBIOLOGICAL URINE CULTURES WITH AND WITHOUT INCUBATION AND PROCESSING WITH BD KIESTRA™ TOTAL LABORATORY AUTOMATION (TLA) FOR A 6-MONTH PERIOD EACH RETROSPECTIVELY, THE TIME TO REPORT WAS SIGNIFICANTLY LOWER IN THE TLA PROCESSED SAMPLES BY 1.5 HOUR IN ADDITION TO TLA SHOWED ENHANCED GROWTH OF NONCLASSICAL AND RARELY CULTURED BACTERIA FROM URINE SAMPLES.
Discover how BD Kiestra™ Solutions can help you:
• Enhance laboratory operations.
• Maximize financial efficiencies.
• Advance laboratory outcomes.
BD Kiestra™ Solutions are enabling laboratories such as yours to meet these changing demands by:
• Offering scalable solutions from sample processing to results reporting
• Leading to accurate, timely and costeffective testing, enabling you to expand your laboratory’s capabilities.
• Enabling secure access to data, ondemand access to analytics with BD Synapsys™ informatics solution, for simplified workflow management and instrument integration
• Improving laboratory productivity, efficiency and turnaround time and helping enable staff efficiency by reducing rework.
Combine high-speed performance and standardized image acquisition to enable dynamic diagnostic imaging:
• See details invisible to the human eye, BD Kiestra™ ReadA contains a 25-megapixel camera with a telecentric lens and ensures plates are oriented for consistency of images over time.
• Improve colony detection and reduce image variability, BD Kiestra™ Optis technology acquires up to 22 images of each plate and determines the optimal value for each pixel using three light sources: top, bottom and side.
The BD Kiestra™ ReadA, maintains consistent temperature and gas levels with negligible heat and CO2 gas loss enabling the first plate images for culture interpretation to
BD KIESTRA™ READA CONTAINS A 25-MEGAPIXEL CAMERA WITH A TELECENTRIC LENS WITH A TELECENTRIC LENS TO IMPROVE COLONY DETECTION AND REDUCE IMAGE VARIABILITY.
be ready as early as after 10 hours for urine specimens and 8 hours for positive blood culture broth subcultures7
BD Kiestra™ Urine Culture Application (UCA)
The BD Kiestra™ UCA uses digital imaging and software algorithms to determine the amount of growth on a urine culture plate from
clean caught and catheterized samples, helping labs maximize their productivity by:
• Auto and Batch reporting samples with no growth or non-significant growth based on user-defined rules.
• Allows for direct identification and differentiation without confirmation testing for some species with BD BBL™ CHROMagar™ media.
THE BD KIESTRA™ UCA USES DIGITAL IMAGING AND SOFTWARE ALGORITHMS.
• Prioritizing and focusing on the critical and complex specimens by organizing those specimens into meaningful worklists in BD Synapsys™ informatics.
• Freeing up staff’s time to focus on critical and complex specimens.
BD Synapsys™ Informatics Solution
Power your automated lab with BD Synapsys™ today to get the right data to the right people at the right time.
Simple, anytime anywhere access to workflow and intuitive personalized user interface, to help you drive productivity.
• Virtual bacteriology enables access to digital reading workflow anytime, anywhere; share information with expert bacteriology staff.
• Intuitive personalized user interface helps you streamline digital reading.
• A single, browser-based informatics platform for microbiology supports multiple instrument types in the workflow.
• Analytics offer actionable insights that help you drive productivity and may impact your lab performance including time to read plates.
• Customize and share worklists by patient demographics and specimen type, to guide staffing needs and streamline productivity.
Smart, intelligent rules engine and actionable insights help you streamline and facilitate decision making.
• Integrated workflow for positive blood cultures across BD BACTEC™, BD Kiestra™ IdentifA and BD Bruker MALDI Biotyper Sirius IVD system.
• Maintain complete specimen and plate traceability for blood culture and MALDI organism ID.
• Integrates imaging applications developed with Artificial Intelligence
THE BD KIESTRA™ UCA USES DIGITAL IMAGING AND SOFTWARE ALGORITHMS TO DETERMINE THE AMOUNT OF GROWTH ON A URINE CULTURE PLATE FROM CLEAN CAUGHT AND CATHETERIZED SAMPLES.
(AI) for automated review of urine culture growth and chromogenic plate screening for MRSA (only available in EU and Canada), standardizing culture interpretation.
• Sophisticated customizable rules engine helps with connectivity, workflow management, and laboratory operations.
• Guided test ordering (by organism, specimen, or culture criteria) standardizes laboratory protocols.
Safe, designed to support data security and privacy control requirements.
• Designed to support data security and privacy control requirements and standards, including GPDR, HIPAA and NIST; BD Synapsys™ is UL CAP and SOC 2 certified (US).
• User activity is stored automatically, creating an audit trail to help support your accreditation, compliance, and QA requirements.
BD Kiestra™ offers comprehensive services that build upon and enhance your automation investment, giving you access to experienced teams of lean workflow consultants, project managers, application specialists, and field service representatives. In conclusion, BD Kiestra™ delivers a timely implementation of your solution to help maximize your system’s uptime, utilization, and laboratory performance.
References:
1. Camporese A. The impact of automation on organizational changes in a community hospital clinical microbiology laboratory. Infez Med. 2004 Jun;12(2):118-25. PMID: 15316298.
2. Angeletti S, De Cesaris M, Hart JG, Urbano M, Vitali MA, Fragliasso F, Dicuonzo G. Laboratory Automation and Intra-Laboratory Turnaround Time: Experience at the University Hospital Campus Bio-Medico of Rome. J Lab Autom. 2015 Dec;20(6):652-8. doi: 10.1177/2211068214566458. Epub 2015 Jan 21. PMID: 25609253.
3. Holland, L. L.; Smith, L. L.; Blick, K. E. Reducing Laboratory Turnaround Time Outliers Reduces Emergency Department (ED) Patient Length of Stay (LOS): An 11 Hospital Study. Am. J. Clin. Pathol. 2005, 124, 672–674.
4. Croxatto A, Dijkstra K, Prod'hom G, Greub G. Comparison of Inoculation with the InoqulA and WASP Automated Systems with Manual Inoculation. J Clin Microbiol. 2015 Jul;53(7):2298-307. doi: 10.1128/JCM.03076-14. Epub 2015 May 13. PMID: 25972424; PMCID: PMC4473203.
5. Klein S, Nurjadi D, Horner S, Heeg K, Zimmermann S, Burckhardt I. Significant increase in cultivation of Gardnerella vaginalis, Alloscardovia omnicolens, Actinotignum schaalii, and Actinomyces spp. in urine samples with total laboratory automation. Eur J Clin Microbiol Infect Dis. 2018 Jul;37(7):1305-1311. doi: 10.1007/s10096-018-3250-6. Epub 2018 Apr 13. PMID: 29651616; PMCID: PMC6015101.
6. Kline KA, Lewis AL. Gram-Positive Uropathogens, Polymicrobial Urinary Tract Infection, and the Emerging Microbiota of the Urinary Tract. Microbiol Spectr. 2016 Apr;4(2): 10.1128/microbiolspec.UTI-0012-2012. doi: 10.1128/microbiolspec.UTI-0012-2012. PMID: 27227294; PMCID: PMC4888879.
7. Antonios K, Croxatto A, Culbreath K. Current State of Laboratory Automation in Clinical Microbiology Laboratory. Clin Chem. 2021 Dec 30;68(1):99-114. doi: 10.1093/clinchem/ hvab242. PMID: 34969105.
8. Culbreath K, Piwonka H, Korver J, Noorbakhsh M. Benefits derived from full laboratory automation in microbiology: a tale of four laboratories. J Clin Microbiol 2021; 59:3.
9. Croxatto A, Marcelpoil R, Orny C, Morel D, Prod’hom G, Greub G. Towards automated detection, semi-quantification, and identification of microbial growth in clinical bacteriology: a proof of concept. Biomed J 2017; 40:317–28.
10. Yue P, Zhou M, Zhang L, Yang Q, Song H, Xu Z, Zhang G, Xie X, Xu Y. Clinical Performance of BD Kiestra InoqulA Automated System in a Chinese Tertiary Hospital. Infect Drug Resist. 2020 Apr 1;13:941-947. doi: 10.2147/IDR.S245173. PMID: 32280250; PMCID: PMC7132006.
BD-134281 August 2024
CHROMagar is a trademark created by Dr. A. Rambach and is the property of Company BALEL.
Cedars-Sinai is proud to be recognized eight years in a row on the “Best Hospitals” Honor Roll and ranked among the top fi ve in the U.S. in six specialties by U.S. News & World Report . As a global leader in healthcare, we offer a full range of services to patients from around the world. Whether we’re providing clinical services in your region, via video visits or at our main campus in Los Angeles, our mission remains unchanged: to give patients access to excellence in healthcare— wherever they may be.
Visual and aesthetic aspects are only half of what we mean by design. Functionality, ergonomics, and user-friendliness can influence patient and hospital outcomes. LINET focuses on the optimization of ambiance, intuitive to use, ergonomics, workflow, and costeffectiveness.
ENHANCED PATIENT OUTCOME
Pressure injuries can be decreased by more than 86%
• Mobilization program powered by lateral tilt, Mobi-Lift, and Mobi-Grips features can positively impact the length of stay and accelerate the recovery process.
• Mobilization programs can reduce the incidence of pressure injuries by up to 86%.
• Easy-to-clean surfaces made of adhesive materials help prevent nosocomial infections.
• Safe side rails, low entry height, and integrated bed lighting help prevent falls.
Vibrations reduced by more than 50%
IMPROVED PATIENT EXPERIENCE
• The integrated USB port allows smart devices to be utilized safely from the bed and enables socialization.
• The integrated compressor of the active mattress reduces vibration by more than 50%, which provides patients with better comfort.
• Undercarriage light helps the patient with orientation in the room at night.
Patient’s turning with less than 67% forces
1.5-day shortened hospital stay
REDUCING THE COST OF CARE
• Mobilization programs can involve the length of hospital stay decreasing by 1.5 days.
IMPROVED CAREGIVER WORKFLOW
• Frame-based lateral tilt enables safe and easier patient handling with less MSD’s prevalence.
• 67% fewer forces needed for turning the patient with lateral tilt.
• Powered castor provides patient transportation without extended effort and risk of injury.
• Smart digital solutions for a remote real-time overview facilitate the daily tasks of caregivers and help them to be more efficient.
Taking a breath might seem simple, but for some, lung function presents a complex puzzle: hidden breathing problems can be a concern for anyone. This is why early detection is key, and that’s where the Medikro Spirometer comes in. This valuable tool, especially the Medikro Pro version, offers a clear picture of lung function, making it a game-changer for healthcare professionals. Forget traditional spirometry’s limitations. The Medikro Pro offers cutting-edge technology, delivering highly accurate lung function measurements. This empowers healthcare professionals to confidently diagnose and monitor respiratory issues like asthma, COPD, and restrictive lung disease - leading to personalized treatment plans and improved patient outcomes.
All of this while prioritizing ease of use : its disposable flow sensors eliminate the need for sterilization, minimizing the time spent and reducing the risk of contamination, as well as its easy connection to PC software featuring an intuitive interface and clear result visualization for quick and efficient analysis. All that being said, Medikro Spirometer, particularly the Medikro Pro model, offers a valuable tool for both healthcare professionals and patients. With its precision, efficiency, and patient-centric design, it paves the way for early detection, accurate diagnosis, and ultimately, a clearer path to easier breathing.
DoH and Penn Medicine to expand collaboration on translational research and second labs in Abu Dhabi
Ahead of its participation at BIO International Convention, in San Diego, USA, The Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector, signed a second Memorandum of Understanding (MoU) with the Perelman School of Medicine at the University of Pennsylvania (“Penn Medicine”) to expand cooperation in education, research and innovation programs. Both parties will further collaborate on translational research ecosystem development as well as launch innovative collaborative research involving “second labs” that leverage and build capabilities in Abu Dhabi and at Penn Medicine in Philadelphia, Pennsylvania, USA in leading-edge areas of science.
The MoU has been signed by Dr. Asma Ibrahim Al Mannaei, Executive Director of the Research and Innovation Centre at the Department of Health – Abu Dhabi and Mick Merritt, Chief
Operating Officer and Lead for Global Clinical Programs, at Perelman School of Medicine at the University of Pennsylvania (Penn Medicine). Reinforcing the Emirate’s strategy to be a leading destination for life sciences, this second MoU establishes that the DoH and Penn Medicine seek to design and develop a translational medicine ecosystem based on Penn’s Institute for Translational Medicine and Therapeutics (ITMAT) that will enable Abu Dhabi to leverage and expand upon the strengths of existing organizations. In addition, the MoU seeks to explore the potential of launching two multi-year collaborative research programs. One focuses on the expanded application of artificial intelligence (“AI”) to identify new potential antibiotics. The other focuses on longitudinal follow-up and genetic analysis of people with Alzheimer’s in Abu Dhabi that will facilitate cross-population comparative analysis and unique attributes that ultimately enable
REINFORCING THE EMIRATE’S STRATEGY TO BE A LEADING DESTINATION FOR LIFE SCIENCES, THIS SECOND MOU ESTABLISHES THAT THE DOH AND PENN MEDICINE SEEK TO DESIGN AND DEVELOP A TRANSLATIONAL MEDICINE ECOSYSTEM BASED ON PENN’S INSTITUTE FOR TRANSLATIONAL MEDICINE AND THERAPEUTICS (ITMAT) THAT WILL ENABLE ABU DHABI TO LEVERAGE AND EXPAND UPON THE STRENGTHS OF EXISTING ORGANIZATIONS. IN ADDITION, THE MOU SEEKS TO EXPLORE THE POTENTIAL OF LAUNCHING TWO MULTI-YEAR COLLABORATIVE RESEARCH PROGRAMS.
Liquid biopsy in breast cancer – Less invasion more precision
Plasma-SeqSensei™
Liquid biopsy in breast cancer – Less invasion more precision
Plasma-SeqSensei™
The Plasma-SeqSensei Breast Cancer IVD Kit is an NGSbased liquid biopsy assay that focuses on highly sensitive detection of clinically relevant mutations in TP53, ESR1, PIK3CA, AKT1 and ERBB2 from blood plasma.
Learn more about the unique advantages of Plasma-SeqSensei technology
The Plasma-SeqSensei Breast Cancer IVD Kit is an NGSbased liquid biopsy assay that focuses on highly sensitive detection of clinically relevant mutations in TP53, ESR1, PIK3CA, AKT1 and ERBB2 from blood plasma.
High sensitivity at low MAFs
Learn more about the unique advantages of Plasma-SeqSensei technology
Down to 0.06% - 0.07% Mutant Allele Fractions.
High sensitivity at low MAFs
Down to 0.06% - 0.07% Mutant Allele Fractions.
Absolute quantification
Short and standardised workflow
From cfDNA samples to results in two days.
Short and standardised workflow
From cfDNA samples to results in two days.
Data analysis and reporting made easy
Generate report designed for clinicians with just a few clicks.
Absolute quantification
Meaningful comparison of ctDNA levels per millilitre of plasma.
Expert voices
Meaningful comparison of ctDNA levels per millilitre of plasma.
Data analysis and reporting made easy
Generate report designed for clinicians with just a few clicks.
Expert voices
‘We know that tissue samples cannot be taken regularly, but liquid biopsy is easy to take, it is simply a sample of blood. And it gives you real-time information.’
‘Even low levels of ctDNA could have given an indication of the coming progression in the follow-up.’
‘There is much more diagnostic power in the absolute quantification.’
Dr Bhuwnesh Agrawal Member of The Supervisory Board Sysmex Inostics and MD, Germany
‘We know that tissue samples cannot be taken regularly, but liquid biopsy is easy to take, it is simply a sample of blood. And it gives you real-time information.’
Dr Bhuwnesh Agrawal Member of The Supervisory Board
Sysmex Inostics and MD, Germany
‘Even low levels of ctDNA could have given an indication of the coming progression in the follow-up.’
‘There is much more diagnostic power in the absolute quantification.’
Prof. Christopher Gebhardt UKE Hamburg, Germany
Prof. Christopher Gebhardt UKE Hamburg, Germany
Prof. Geert A. Martens AZ Delta General Hospital, Belgium
Prof. Geert A. Martens AZ Delta General Hospital, Belgium
prevention and early diagnosis. With the aim of bridging the gap between preliminary research and practical applications in medical practices, translational research seeks to translate research discoveries from laboratory findings and clinical studies into practical applications to improve human health.
Dr. Asma Ibrahim Al Mannaei, Executive Director of the Research and Innovation Centre at the Department of Health – Abu Dhabi, said: “With a successful history of collaboration with Penn Medicine, the Department of Health –Abu Dhabi is thrilled to build on this partnership which underscores the crucial importance of synergy between academia and regulatory bodies in enabling research development and innovation. Abu Dhabi continues to spearhead global collaboration on the global stage and facilitate knowledge and experience sharing in reflection of its commitment to driving forward a future where innovative healthcare solutions are accessible to all.”
Leveraging Abu Dhabi’s advanced infrastructure and Penn Medicine’s renowned expertise in discovering and developing novel treatments, the collaboration will potentiate the development of a translational medicine and therapeutics ecosystem to further enable capacity development and the creation of novel discoveries and treatments to be developed in Abu Dhabi. This will involve the development of research training and educational programs for healthcare professionals to upskill the workforce in various healthcare domains including medical science, biomedical research and health technology.
Glen Gaulton, PhD, Vice Dean and Director of the Center for Global Health at Penn’s Perelman School of Medicine said: “Penn Medicine has become a global leader in precision medicine and innovation that has resulted in more than 25 new drugs and therapies approved by the U.S. Food and Drug Administration in the past several years. These accomplishments were catalyzed by the transformational investment in ITMAT 20 years ago which has
developed a translational research ecosystem, enriched our human capital and incentivized interdisciplinary and translational research. We look forward to collaborating with our colleagues in Abu Dhabi to replicate this structure in parallel with investment in “second labs” to foster interactions focused on specific challenges and opportunities in translational research. This will advance the capacity of Abu Dhabi to pursue its vision to become a true innovator in the biomedical sciences and a regional leader that will make a global impact.”
Led by the Department of Health – Abu Dhabi (DoH), a high-profile Abu Dhabi delegation headed by His Excellency Mansoor Ibrahim Al Mansoori, Chairman of the DoH, visited the United States of America (USA) between May 29th,2024 and June 5th,2024 to showcase the Emirate’s partnership opportunities and explore collaboration with leading organizations in Research and Development (R&D), manufacturing and innovation. Kickingoff in Philadelphia, delegates have met with existing and new partners to foster collaboration with leading education research institutions, governmental bodies and health-tech giants. The transnational mission has culminated in San Diego, coinciding with Abu Dhabi’s participation at BIO International Convention 2024 to exhibit the Emirate’s growth and development of its biotechnology industry. The participation has witnessed in-depth discussions, shared insights and expertise as well as explored collaborations in health-tech, life science and innovation.
Highlighting the rich diversity and expertise within Abu Dhabi’s ecosystem, the Delegation comprised of 20 key entities including the Department of Health – Abu Dhabi (DoH), Abu Dhabi Investment Office (ADIO), Abu Dhabi Executive Office (ADEO), G42, Masdar City, Mubadala Investment Company, Khalifa Economic Zones Abu Dhabi Group (KEZAD), Malaffi, The Medical Office, Ambulatory Healthcare Services, PureHealth, One Health, M42, Technology Innovation Institute (TII), Burjeel Holdings, Khalifa University, Abu Dhabi Holding Company (ADQ), Abu Dhabi Stem Cell Centre (ADSCC) and Etihad Airways.
LEVERAGING ABU DHABI’S ADVANCED INFRASTRUCTURE AND PENN MEDICINE’S RENOWNED EXPERTISE IN DISCOVERING AND DEVELOPING NOVEL TREATMENTS, THE COLLABORATION WILL POTENTIATE THE DEVELOPMENT OF A TRANSLATIONAL MEDICINE AND THERAPEUTICS ECOSYSTEM TO FURTHER ENABLE CAPACITY DEVELOPMENT AND THE CREATION OF NOVEL DISCOVERIES AND TREATMENTS TO BE DEVELOPED IN ABU DHABI.
With a vast and diverse portfolio, Pharmatrade offers over 5000 high-quality products. These encompass a wide array of medical and pharmaceutical supplies, catering to various healthcare needs. Pharmatrade's product range is carefully curated to meet the requirements of both the Government and Private sectors in the UAE. What We Do
46
5,000+ Products
Asan – UAE Gastroenterology Hospital in Dubai Healthcare City Phase 2 represents a milestone in the advancement of Dubai’s healthcare offerings Dubai’s first integrated hospital specialising in gastroenterology breaks ground
Dubai Healthcare City Phase 2 witnessed the groundbreaking ceremony of the Asan – UAE Gastroenterology Hospital, the emirate’s first integrated hospital specialised in gastroenterology. This significant milestone in the advancement of Dubai's healthcare landscape marks the first international venture of Asan Medical Center (AMC), South Korea’s largest hospital. The new hospital is being developed by AMC in partnership with Scope Investment, a UAE-based investment group.
The groundbreaking ceremony, held at DHCC Phase 2, was attended by His Excellency Awadh Seghayer Al Ketbi, Director General of the Dubai Health Authority; His Excellency Moon
Byung Jun, Consul General of the Republic of Korea in Dubai; Issam Galadari, Chief Executive Officer of the Dubai Healthcare City Authority (DHCA); Dr. Soo-Sung Park, Chief Financial Officer and Paediatric Orthopedic Surgeon at Asan Medical Center; Najib Fayyad, Chief Executive Officer at Scope Investment; Dr. Saeed Al Dayeh, General Manager, Health Care Sector at Scope Investment, and other senior officials from DHA, DHCA and Scope Investment.
Scheduled for completion by 2026, the Asan – UAE Gastroenterology Hospital will significantly increase the UAE’s capacity in critical areas such as digestive health, gastrointestinal oncology, liver transplantation management, and lifestyle diseases. By
AMC WILL PROVIDE ADVANCED HEALTHCARE SERVICES AND EDUCATION IN GASTROENTEROLOGY AT THE NEW FACILITY.
providing advanced healthcare services and education in gastroenterology, the new hospital will contribute to bolstering Dubai’s specialised medical offerings. The hospital will also expand the range of services within the DHCC ecosystem, further solidifying its position as an enabling healthcare and wellness destination.
Speaking on the occasion, His Excellency Awadh Seghayer Al Ketbi highlighted that the tremendous developments witnessed by Dubai’s health sector, combined with its distinctive investment climate that has fostered growth in this vital sector, and the increasing demand for high-quality health services, have transformed the emirate into a major healthcare destination and an important location for the headquarters of major international hospitals and medical centres. He added that Dubai’s ability to continuously upgrade its healthcare infrastructure, attract top-tier medical professionals, and foster a culture of excellence in patient care, has also contributed to this transformation.
His Excellency Moon Byung Jun said: "Asan Medical Center is a leading hospital in Korea, and we congratulate them on the establishment of their first gastroenterology hospital outside of Korea in Dubai through the collaboration with Scope Investment and the Dubai Healthcare City Authority. We look forward to providing the best healthcare services to patients not only in the UAE but the whole GCC region and around the world through this hospital."
Issam Galadari said, “Asan – UAE Gastroenterology Hospital represents an important milestone in the ongoing development of DHCC Phase 2, underscoring our drive to enable specialised healthcare by attracting globally renowned institutions and expertise. This partnership contributes significantly to our efforts to build our ecosystem to cater to the evolving demands of the UAE’s health sector. It is a testament to our dedication to providing highquality specialied healthcare services through strategic local and international partnerships,
in line with Dubai’s objective of attracting key investments across various sectors.”
Spanning 21,150 square metres, the hospital will encompass two basement levels and seven floors, offering 65 beds, including royal and VIP rooms, four operating theatres, and comprehensive gastroenterology care for adults and children. Specialities will include endoscopy, bariatrics, treatment for gastrointestinal oncology, management of liver transplantation and gastrointestinal health check-up. Additional support facilities will include rehabilitation services for related diseases, outpatient clinics, ICU and one-day care unit. Moreover, AMC aims to enhance local healthcare standards by serving as an educational hub in the Middle East. This includes educating local medical professionals and integrating expertise from South Korea by bringing a medical team to join the Asan – UAE Gastroenterology Hospital.
Dr. Soo-Sung Park said: “We are dedicated to delivering a comprehensive range of gastrointestinal services at Asan – UAE Gastroenterology Hospital, prioritising safety and efficiency. We emphasise minimally invasive procedures and preventive care, supported by a multidisciplinary approach to enhancing patient outcomes and promoting overall digestive health. Our commitment extends to maintaining rigorous safety standards and utilising state-of-the-art technology, ensuring that every patient receives the best possible care in managing their digestive health.”
Najib Fayyad said: “Asan – UAE Gastroenterology Hospital will be a state-of-the-art facility dedicated to providing comprehensive and advanced gastroenterological care. This investment complemented by the support of DHA and DHCC underscores our commitment to improving the quality of life of the community by providing superior medical services and innovative healthcare solutions. The new hospital will not only elevate healthcare standards but also contribute to the economic and social wellbeing of the region.”
NEW SPECIALISED HOSPITAL MARKS THE FIRST INTERNATIONAL VENTURE OF ASAN MEDICAL CENTER (AMC), SOUTH KOREA’S LARGEST HOSPITAL.
Ghaith Abu-Zeinah, M.D.
Assistant Professor of Medicine, Division of Hematology and Oncology,
"The general symptoms of MPNs include fatigue, headaches, weight loss, and night sweats."
Dr. Ghaith Abu-Zeinah is an Assistant Professor of Medicine in the Division of Hematology and Oncology at Weill Cornell Medicine in New York, an assistant attending physician at NewYork-Presbyterian Hospital, and a visiting faculty member at Weill Cornell Medicine-Qatar (WCM-Q). Dr. AbuZeinah, an alumnus of WCM-Q, specializes in myeloproliferative neoplasms (MPNs), a rare type of blood cancer. He teaches, conducts workshops, and collaborates with discussion groups to raise awareness about MPNs, other chronic conditions, and premalignant states that can lead to leukemias. Dr. Abu-Zeinah spoke with "Hospitals" magazine on the importance of raising awareness about myeloproliferative neoplasms (MPNs)—blood cancers that can cause life-threatening conditions.
Can you describe myeloproliferative neoplasms (MPNs)?
Myeloproliferative neoplasms (MPNs) are rare blood cancers of stem cell origin that differentiate into myeloid lineage. MPNs are characterized by abnormal proliferation of blood cells and can manifest as either chronic or acute conditions.
Patients with MPN experience an overproduction of white blood cells, red blood cells, and/or platelets. The three classical types of MPNs include essential thrombocythemia (ET), polycythemia vera (PV), and primary myelofibrosis (PMF). ET and PV are the most common MPNs. PV is characterized by high red cell counts, with or without elevations in white cells and platelets, whereas in ET, the elevation in platelets is the sole blood count abnormality. In
"PMF IS CONSIDERED THE MOST AGGRESSIVE MPN, WHERE THE MUTATED STEM CELLS CAUSE BONE MARROW INFLAMMATION AND SCARRING. AS A RESULT, SOME PMF PATIENTS DEVELOP VERY LOW BLOOD COUNTS (CYTOPENIAS), ENLARGED SPLEENS, AND INFREQUENTLY, ACUTE MYELOID LEUKEMIA."
INTERVIEWS
both conditions, more so with PV, patients are at greater than average risk of having venous or arterial blood clots, including potentially fatal pulmonary emboli, heart attacks, and strokes. PMF is considered the most aggressive MPN, where the mutated stem cells cause bone marrow inflammation and scarring. As a result, some PMF patients develop very low blood counts (cytopenias), enlarged spleens, and infrequently, acute myeloid leukemia. ET, PV, and PMF are driven by genetic mutations that augment hematopoiesis (stimulating blood cell production). The most common mutation is in the Janus kinase 2 (JAK2) gene, followed by calreticulin (CALR) and the thrombopoietin receptor (MPL).
Although these blood cancers are rarely fatal, some may cause life-threatening conditions such as heart attacks, strokes, transfusion-dependent anemia, or acute leukemia.
Unlike other types of cancers, there is no formalized screening guideline for MPNs. These conditions are typically detected during annual health check-ups, where Complete Blood Count (CBC) and other tests are performed. Since many individuals carry mutations without knowing, early detection and treatment in the premalignant state may be useful to prevent the condition from worsening. Further research is needed on the role and benefit of early screening and preventative strategies.
What are some common symptoms of MPNs?
The general symptoms of MPNs include fatigue, headaches, weight loss, and night sweats. A specific symptom more common in PV is aquagenic pruritus, which is itching triggered by contact with water, typically after showers. That said, the World Health Organization (WHO) has set criteria for diagnosing MPNs. For example, one major criterion for PV diagnosis is an elevated red blood cell count, indicated by high hemoglobin levels (over 16 grams per deciliter (g/dl) for females or 16.5 g/dl
for males). Confirmation of PV involves the presence of the JAK2 mutation and requires a bone marrow biopsy.
Who is impacted by MPNs?
The prevalence and incidence of MPNs in the Middle East and Asia “were estimated to be 5781 and 12-15 per 100,000 hospital patients per year,” according to the MERGE Registry analysis by Dr. Yassin et al in 2020. The prevalence of the premalignant state known as clonal hematopoiesis of indeterminate potential (CHIP), where individuals carry the mutation without a formal MPN diagnosis, is likely much higher.
The median age of diagnosis for MPNs is in the early 60s, but the median age at some academic centers is in the 50s. MPNs have also been diagnosed less commonly in children, adolescents, and young adults.
Genetic research has identified that the most common underlying mutation for these blood cancers, usually in the JAK2 gene, can develop up to 20 years before clinical diagnosis. In some cases, this mutation can occur in utero, meaning a baby can develop the mutation in the womb and be diagnosed with MPNs later in life.
How do you treat patients with MPNs?
MPNs patients undergo cytoreductive treatment to help reduce blood counts. Additionally, those with PV undergo phlebotomy therapy to reduce the red blood cell count and decrease the risk of blood clots. The first-line cytoreductive therapies depend on the type of MPN one has, age, symptoms, and other clinical factors. The approved treatment options include oral chemotherapy (such as hydroxyurea), oral targeted JAK inhibitors (such as ruxolitinib), and subcutaneous injection of an immunotherapeutic drug (interferon alfa). Clinical trials of investigational agents with or without standard treatments may also be available. The approved drugs can lead to clinical remission but are not curative. If patients can
"THE MEDIAN AGE OF DIAGNOSIS FOR MPNS IS IN THE EARLY 60S, BUT THE MEDIAN AGE AT SOME ACADEMIC CENTERS IS IN THE 50S. MPNS HAVE ALSO BEEN DIAGNOSED LESS COMMONLY IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS. GENETIC RESEARCH HAS IDENTIFIED THAT THE MOST COMMON UNDERLYING MUTATION FOR THESE BLOOD CANCERS, USUALLY IN THE JAK2 GENE, CAN DEVELOP UP TO 20 YEARS BEFORE CLINICAL DIAGNOSIS. IN SOME CASES, THIS MUTATION CAN OCCUR IN UTERO, MEANING A BABY CAN DEVELOP THE MUTATION IN THE WOMB AND BE DIAGNOSED WITH MPNS LATER IN LIFE."
remain on these drugs for years or decades without disease progression, they do not need a transplant. However, if the disease progresses, a bone marrow transplant may be required. An allogeneic, matched-donor stem cell transplant is typically carried out for myelofibrosis patients (PMF or secondary myelofibrosis after ET or PV) or patients with MPNs that are accelerating to leukemia. Providing the best standard of care to MPNs patients also involves collaboration with various health professionals, including hematopathologists, bone marrow transplant hematologists, oncologists, cardiologists, neurologists, and other specialists. These collaborations are crucial for identifying gaps in care, understanding patient needs, determining how best to support patients, and planning the most effective steps toward progress. Beyond medical interventions, MPNs patients may benefit from lifestyle modifications such as regular exercise, a balanced diet, yoga, and meditation, which may help manage symptoms.
What are the advancements in treating MPNs?
Current treatments include chemotherapy, immunotherapy, and targeted agents. These treatments help ease symptoms and reduce the risk of MPNs developing into a more serious disease. The JAK2 mutation was discovered in 2005, and several years later, research led to a series of newly approved Food and Drug Administration (FDA) drugs, primarily JAK inhibitors. Three JAK inhibitors—fedratinib, pacritinib, and momelotinib—have been approved after ruxolitinib.
While some of these inhibitors are more specific for JAK2 or target additional pathways, none are curative. Research is ongoing to determine whether there is a better JAK inhibitor or whether another drug must be added in combination. Different classes of drugs, including inhibitors of BET, BCL2/BCLxL, MDM2, telomerase, PIM1 kinase, CALR, and others, are currently being explored in clinical trials.
Explore our diverse range of Continuing Professional Development (CPD) opportunities by staying updated on our forthcoming events. Visit our website and follow our social media channels for the latest information and updates: https://qatar-weill.cornell.edu/continuing-professional-development/
Understanding the Female Reproductive System
The female reproductive system is a complex and intricate network of organs and structures that play a crucial role in women's overall health and well-being. It is essential for menstruation, fertility, pregnancy, and hormonal balance, making its health and functionality of paramount importance. Understanding the female reproductive system can empower women to make informed decisions about their health and recognize the signs and symptoms of potential issues.
Two significant diseases that affect many women worldwide are Cervicitis and Polycystic Ovary Syndrome (PCOS). Both conditions can have profound impacts on a woman's reproductive health, yet they are often misunderstood or overlooked.
Understanding the female reproductive system, particularly focusing on cervicitis and PCOS, helps women comprehend these conditions, including their causes, symptoms, and available treatments. By increasing awareness and knowledge, we can promote better health outcomes and a higher quality of life for women affected by these common yet impactful diseases.
CERVICITIS
What is the Relationship Between Hormonal Imbalance and Infection?
Cervicitis can be caused by various factors such as bacterial infections, viral infections, and sexually transmitted diseases. These can lead to uncomfortable symptoms and potential complications. Therefore, it is important for every woman to familiarize herself with the causes and symptoms of cervicitis for prevention. Diagnosis and treatment are crucial for effective management and overall reproductive health.
Sexually transmitted infections, especially those transmitted sexually, are a significant cause of cervicitis. This condition is often associated with sexually transmitted pathogens such as chlamydia and herpes simplex virus, among others. These infections can lead to
inflammation in the cervix, resulting in the characteristic symptoms of this condition.
Symptoms can vary from one woman to another, and in some cases, cervicitis may be asymptomatic. Symptoms may include abnormal vaginal discharge (which can be yellow, gray, or green in color), pain or discomfort, vaginal bleeding outside of menstruation, and pelvic pain. It is essential for women to be aware of these symptoms and seek the necessary medical care for proper evaluation and diagnosis.
Hormones and Cervicitis
The overall hormonal balance in a woman's body affects the health of the reproductive system. When there is a hormonal imbalance, it can lead to changes in the environment of the uterus and cervix, making them more susceptible to infections, including cervicitis.
Hormonal imbalance occurs due to a deficiency of estrogen or an excess of progesterone, resulting in a reduced ability of the body to maintain the health of cervical tissue, which leads to inflammation. Estrogen is important for maintaining the health of the vaginal lining and helps to protect it from infections. A lack of estrogen, such as during menopause or when using contraceptive pills, can weaken the vaginal lining and make it more prone to infections, including cervicitis.
On the other hand, progesterone regulates mucus secretion in the vagina, which helps protect the cervix from bacteria. A shortage of progesterone can reduce mucus flow, making the cervix more susceptible to infections.
Pregnancy and Cervicitis
During pregnancy, cervicitis can cause discomfort and may lead to complications for both the mother and baby if not addressed. Causes of cervicitis during pregnancy include hormonal imbalances, poor personal hygiene, changes in the vaginal environment, tight underwear, and untreated gynecological infections.
If left untreated, cervicitis during pregnancy can result in preterm labor, miscarriage, infections in the newborn's eyes and lungs, an increased risk of premature rupture of membranes, and fetal infection.
Developmental anomalies
Tumors
Trauma
Cervicitis
Treatment for cervicitis during pregnancy typically involves a combination of oral antibiotics and gynecological suppositories to increase the effectiveness of the treatment.
However, it is crucial for pregnant women to take preventive measures against cervicitis, such as maintaining personal hygiene, choosing breathable underwear materials, and avoiding harsh detergents and cleaning solutions.
Women with cervicitis can still become pregnant, but chronic cervicitis can lead to a high rate of female infertility. The impact on fertility depends on factors such as age, physical condition, severity of the disease, and treatment methods used.If a woman has been fully treated for cervicitis or has mild cervicitis, it will not significantly affect her ability to become pregnant. On the other hand, if a woman develops cervicitis during pregnancy, it is important to seek immediate medical attention to receive a treatment plan that can help prevent complications.
Diagnosis
Cervicitis can be caused by several sexually transmitted diseases, as well as other factors such as irritation, injury, or allergies. It is important to determine the cause of cervicitis in order to provide the patient with appropriate treatment, as there are concerns about the infection spreading beyond the cervix and causing serious complications if left untreated.
Cervicitis is typically diagnosed during a pelvic exam by a gynecologist. The doctor will examine the cervix for signs of inflammation, such as redness, swelling, and discharge.
A sample from the cervix may be taken for laboratory testing to identify any underlying infections, such as chlamydia, gonorrhea, herpes, or trichomoniasis. Sometimes, a Pap smear may also be performed to check for abnormalities in the cervical cells.
Latest Treatments
The goal of cervicitis treatment is to address the underlying cause of inflammation. Antibiotics are typically prescribed for bacterial infections, while antiviral medications may be used for viral infections. New treatments for cervicitis include:
• Laser Therapy: This treatment uses laser beams to destroy the infected tissue in the cervix.
• Cryotherapy: This treatment involves freezing the infected tissue in the cervix.
• Radiofrequency Therapy: This treatment uses radio waves to heat and destroy the infected tissue in the cervix. These treatments can be effective in treating genital warts caused by the human papillomavirus (HPV).
• Immunotherapy: This treatment is used to boost the immune system to fight off HPV infections. This therapy is still under research and development but may offer hope for the prevention and treatment of cervical cancer in the future.
• Non-surgical treatment options for cervicitis include the use of medications, ointments, and lifestyle changes, depending on the cause of the inflammation.
• Antibiotics: These are used to treat bacterial cervicitis, with the type and duration of antibiotic treatment determined by the doctor based on the type of bacteria and the severity of the infection.
• Antiviral Medications: While there is no cure for HPV, which causes genital warts, these medications can be used to reduce the amount of the virus in the body and prevent its spread.
• Antiprotozoal Drugs: These are used in rare cases to treat cervicitis caused by parasites.
• Topical Ointments: These can be used to treat genital warts caused by HPV.
How to Prevent Cervicitis
To prevent cervicitis, you can take specific steps such as:
• Maintaining Good Hygiene: Wash the sensitive area with warm water and mild soap, and avoid using douches or scented vaginal products as they may irritate the area. It is best to wear loose-fitting cotton underwear that allows air to circulate and to change underwear regularly.
• Regular Check-ups: Regular Pap smears help detect early changes in cervical cells that could lead to cervical cancer.
• Strengthening the Immune System: Eat a healthy diet, ensuring adequate intake of fruits, vegetables, and whole grains. Regular exercise, adequate sleep, and stress reduction can all contribute to a stronger immune system.
• HPV Vaccination: It is recommended for girls and boys at age 11 or 12. The HPV vaccine can help prevent HPV infection, thereby reducing the risk of genital warts and cervical cancer.
POCS
For Every Woman Suffering from Polycystic Ovary Syndrome... What to Eat and What to Avoid?
Polycystic Ovary Syndrome (PCOS) is a hormonal disorder that affects about one in ten women, causing a range of physical and psychological problems. Women with PCOS often experience issues related to obesity and weight gain. However, it is possible to manage PCOS by following a healthy diet and engaging in regular physical activity.
Exploring the Link Between PCOS and Obesity
First, it is necessary to emphasize certain aspects of this syndrome in order to demonstrate the relationship between PCOS and obesity. In cases of PCOS, the ovaries produce an excessive amount of male hormones called androgens, which should only be present in small amounts in women. While the exact cause of cysts is not confirmed, some cases involve a combination of genetic predisposition and environmental factors, including diet and physical activity, all of which contribute to the onset of symptoms.
What is the
connection between
obesity and PCOS?
It seems that women with obesity are at a greater risk of developing PCOS, and women with PCOS are at a greater risk of becoming obese. Many women with PCOS have insulin resistance, which means their bodies cannot use insulin effectively. This causes insulin levels to build up in the body and may lead to higher levels of androgens.
Obesity can also increase insulin levels and worsen PCOS symptoms. Women with PCOS either produce large amounts of insulin or their insulin does not work as it should. This means that the inability of insulin to function normally is one reason for weight gain or difficulty losing weight in women with PCOS. On the other hand, some women may develop PCOS later after significant weight gain.
PCOS is characterized by insulin resistance.
Research indicates that about 70% of women with this syndrome suffer from insulin resistance and consider it a primary cause. In these cases, the body cannot supply cells with enough glucose, prompting the pancreas to produce more insulin to help maintain blood glucose levels.
Diet is Half the Treatment
Women with PCOS need to follow a healthy diet and regular exercise regimen continuously, as achieving a healthy weight and losing excess weight can reduce the risk of cardiovascular diseases and diabetes and help alleviate the symptoms associated with PCOS. Women must first realize that half of the treatment depends primarily on their efforts. Once diagnosed, they should follow a diet suitable for their condition to protect themselves from obesity and its risks, gradually shedding excess weight. Exercise is essential in such cases; it is the first step towards treatment because obesity itself exacerbates hormonal imbalances.
Although some women may not lose weight through diet and exercise alone, studies have shown long-term benefits, such as improved carbohydrate (glucose) metabolism and enhanced insulin sensitivity, which can help prevent the development of diabetes. When the body's sensitivity to insulin decreases, the pancreas increases its production to compensate.
Weight loss is very important for women, not only for its health benefits but also for its impact on energy levels. Even if exercise does not lead to immediate weight loss, the overall health benefits remain significant.
What is the Suitable Diet?
Some studies have shown that the keto diet is suitable for PCOS cases due to its low carbohydrate content and high levels of healthy fats and protein.
This diet helps in losing excess weight and reduces insulin resistance in the body. Women should follow a low-calorie diet that includes nutrients that help regulate blood sugar and reduce insulin resistance, such as fiber, lean protein, antioxidants, omega-3 fatty acids, and healthy fats, while avoiding simple sugars, refined carbohydrates, and saturated fats.
Healthy ovary
Polycystic ovary
For individuals with PCOS, it is essential to consume a diet abundant in the following foods:
• Fiber: Vegetables, nuts, quinoa, and buckwheat, especially for breakfast and lunch.
• Dark Leafy Greens: Kale, spinach, arugula, and Swiss chard.
• Plant-Based Proteins: Lentils, chickpeas, and beans instead of animal protein to reduce saturated fat intake.
• Anti-inflammatory Foods: Turmeric, berries, hot peppers, fatty fish (salmon), mushrooms, green tea, and olive oil.
• Processed Carbohydrates: Cereals, biscuits, chips, pastries, and white bread.
• Dairy Products: Milk, cheese, yogurt, and ice cream.
• High Glycemic Index Carbohydrates: White bread, potatoes, canned corn, cornflakes, watermelon, figs, and dried dates.
• Refined Sugars: Fructose, cakes, and sweets.
• Red Meat.
• Trans Fats and Hydrogenated Fats: Fried foods.
• Artificial Sweeteners.
Clemenceau Medical Center, Beirut-Lebanon
Introduces Cutting-Edge Medical Imaging Devices
Dr. Ghida Mouharram Choureiki
Head of Diagnostic Imaging / Radiology Unit
"Modern Medical Devices: Less Radiation and More Comfort."
Clemenceau Medical Center (CMC), Beirut- Lebanon has recently enhanced its Diagnostic Imaging / Radiology Unit by integrating state-of-the-art medical imaging devices, aligning with the latest technological advancements to elevate patient care. This upgrade marks a significant step towards improving the quality of services provided to patients, ensuring they receive the best possible healthcare. "Hospitals" magazine had the privilege of interviewing Dr. Ghida Mouharram Choureiki, Head of the Diagnostic Imaging /Radiology unit at CMC, to discuss the remarkable features of the new devices and their impact on enhancing patient experience and service quality.
CMC has recently upgraded its Radiology unit with advanced devices. Can you elaborate on these devices and their distinguishing features?
CMC remains at the forefront of healthcare by continually embracing the latest advancements across various fields. Recognizing the critical role of medical imaging in accurate disease diagnosis, the center has recently acquired four cutting-edge devices: Magnetic Resonance Imaging (MRI), Mammography, Ultrasound, and Computed Tomography (CT scan). These devices significantly reduce radiation exposure by over 50% compared to older models, which is particularly crucial for vulnerable groups like the elderly with chronic conditions and children.
Additionally, these modern devices drastically shorten imaging times. For instance, an MRI brain scan that previously required 30 to 40 minutes now takes only about 11 minutes,
increasing patient throughput and comfort by minimizing anxiety and stress.
Does this mean that doctors can now obtain more precise diagnoses and tailor treatment plans more effectively to each patient's condition?
Certainly. Modern medical imaging devices are pivotal in early disease detection, enhancing diagnostic accuracy, formulating appropriate treatment plans, and reducing treatment costs. Regular screenings with these advanced devices are essential as early detection significantly improves recovery outcomes, making treatments more effective and cost-efficient.
With an increasing focus on subspecialties within radiology, how is this affecting the training and expertise of radiologists?
Radiology is witnessing a growing emphasis
CMC REMAINS AT THE FOREFRONT OF HEALTHCARE BY CONTINUALLY EMBRACING THE LATEST ADVANCEMENTS ACROSS VARIOUS FIELDS
INTERVIEWS
on sub-specialization, with radiologists pursuing additional two-year training programs to deepen their expertise in specific areas. This specialized knowledge allows for more precise disease diagnosis, significantly enhancing the quality of care.
What measures has CMC taken to train staff on using these new devices?
Training our staff is an integral part of upgrading the Radiology Unit at CMC. By investing in the development of our team’s skills, we ensure optimal utilization of the new devices, enhance service quality, and improve patient satisfaction. All technicians, radiologists, and department staff underwent a comprehensive two-week training course conducted by the device manufacturers.
This training included detailed instructions on operating the devices, highlighting their features, and addressing all queries from the trainees. Additionally, ongoing remote training is provided for up to six months to address any further questions and offer necessary support from the manufacturer.
Could you shed light on the advancements in radiology in the context of artificial intelligence?
The field of radiology is experiencing a revolutionary transformation driven by rapid advancements in artificial intelligence (AI) and deep learning technologies.
These innovations have significantly enhanced the capabilities of imaging devices, providing radiologists with unprecedented diagnostic precision and efficiency.
Integrating AI enables imaging devices to detect diseases at earlier stages with greater clarity, including cancers as small as 2 mm, which posed a significant challenge in the past. AI has also substantially improved image accuracy, making them clearer and easier for radiologists to interpret and diagnose conditions accurately.
How does AI enhance the role of the radiologist?
AI serves as a powerful tool for radiologists, improving diagnostic accuracy, reducing imaging time, and enhancing overall efficiency.
However, the radiologist remains the
RADIOLOGY IS WITNESSING A GROWING EMPHASIS ON SUBSPECIALIZATION, WITH RADIOLOGISTS PURSUING ADDITIONAL TWOYEAR TRAINING PROGRAMS TO DEEPEN THEIR EXPERTISE IN SPECIFIC AREAS
final decision-maker in diagnosis, leveraging their expertise to evaluate medical images, identify diseases accurately, and effectively communicate with patients.
While AI algorithms enhance image clarity and provide valuable insights, they serve as an assistive tool rather than a replacement for the radiologist’s expertise.
For example, AI can analyze mammogram images to identify calcifications accurately but cannot distinguish between benign and malignant ones. This critical evaluation is where the radiologist’s expertise is indispensable. The radiologist’s ability to correlate clinical results with medical images is essential for accurate diagnosis and the identification of rare or complex diseases.
Direct communication with patients, explaining imaging results, answering their questions, and providing psychological support, remains paramount.
Conclusion
The integration of advanced medical imaging devices at Clemenceau Medical Center represents a significant advancement in patient care. By reducing radiation exposure, shortening imaging times, and enhancing diagnostic accuracy, these devices set a new standard for medical imaging.
The ongoing commitment to staff training and the incorporation of artificial intelligence further underscore CMC’s dedication to providing the highest quality healthcare.
Enhancing Safety and Hygiene
Modern Practices in Hospital Cleanliness and Food Safety Inspired by the Hotel Industry
Hospitals and clinics are places of healing and comfort, but they can also be hotspots for the spread of germs and bacteria. Due to the widespread use of antibiotics, medical facilities often resist traditional cleaning practices, making them more prone to infections. Hospital-acquired infections (HAIs) and other complications can disrupt care, affect patient satisfaction, increase healthcare costs, and prolong recovery times. To address these challenges, numerous companies have emerged, providing high-quality cleaning, infection control, and healthy meal services to create safe and reliable healthcare environments. Often, these companies adopt practices from the hotel industry to offer upscale, modern care.
HOSPITAL CLEANLINESS AND FOOD SAFETY
Cleanliness and Patient Safety
The importance of hygiene and disinfection in hospitals and healthcare centers cannot be overstated. These institutions understand the necessity of maintaining a sterile environment to ensure patient safety and visitor satisfaction. However, the complexity of these tasks has increased with medical advancements. The evolution of hospital care has led to the adoption of high-end, hotel-like practices in cleaning, disinfection, and food preparation and service.
Failures in properly disinfecting medical equipment, such as endoscopes, have often led to disease outbreaks. Healthcare providers must be aware of current issues like the role of the environment in disease transmission, reprocessing of semi-critical items, and new technologies like hydrogen peroxide vapor. Multiple studies in different countries have documented outbreaks due to noncompliance with recommended reprocessing procedures. The CDC and FDA in the United
States have issued health advisories to alert healthcare providers about the need for proper maintenance, cleaning, and sterilization of reusable medical devices.
Earl H. Spaulding's 15 rational approaches to disinfecting and sterilizing patient care equipment, established nearly 50 years ago, remain highly effective. Spaulding's classification system categorizes tools and items based on the infection risk they pose, helping infection control professionals plan effective disinfection or sterilization methods. Modern studies suggest current reprocessing guidelines are insufficient to ensure successful decontamination. To minimize patient risk and ensure proper training, initial and annual competency testing for all individuals involved in reprocessing medical tools is necessary.
Importance of Hygiene in Healthcare
Disinfection and sanitation are crucial infection control measures in hospitals and other healthcare settings, keeping germs at bay and preventing their spread. Healthy individuals have various defenses against infections, such as intact skin protecting the immune system from external threats. However, many patients in healthcare settings are already weakened, making them more susceptible to infections. Proper cleaning in healthcare environments is essential to reduce the risk of infection, protect patient and staff well-being, and maintain compliance with industry standards.
To achieve the desired results, an effective sanitation schedule must ensure that the medical facility not only appears clean but is also safe. Different areas within a healthcare facility require varying sanitation methods and frequencies based on the activities conducted and the infection risk level. Minimizing cross-
DISINFECTION AND SANITATION ARE CRUCIAL INFECTION CONTROL MEASURES IN HOSPITALS AND OTHER HEALTHCARE SETTINGS, KEEPING GERMS AT BAY AND PREVENTING THEIR SPREAD. HEALTHY INDIVIDUALS HAVE VARIOUS DEFENSES AGAINST INFECTIONS, SUCH AS INTACT SKIN PROTECTING THE IMMUNE SYSTEM FROM EXTERNAL THREATS.
contamination during cleaning is vital, which can be achieved through a color-coded cleaning system and appropriate protective gear for sanitation staff. While sanitation requirements in healthcare can be daunting and timeconsuming, transferring responsibility to team members may result in suboptimal practices. Training staff to meet strict regulatory standards will consume significant time and divert focus from patient care.
Kitchen and Food Safety Procedures
The role of infection prevention in the kitchen is often overlooked. Kitchens contain numerous sensors monitored daily, monthly, quarterly, and annually to ensure safe food storage and delivery for staff, patients, and families. The goal is to prevent biological (bacterial, fungal, parasitic), chemical (cleaners, disinfectants), and physical (metal shavings, dust, dirt, basic food particles) contamination.
From full-service restaurants and hotels to hospitals and healthcare facilities, regular sanitation and disinfection are essential for food safety. Many foodborne illness outbreaks result from poor cleaning and disinfection practices. Kitchen elements require different approaches to cleaning and disinfection, considering factors like the item being cleaned, the type of dirt, water supply, suitable cleaning and disinfecting agents, and common cleaning methods such as manual, mechanical, and in-place cleaning. For food safety, disinfection must always follow cleaning.
Hotel-Style Food Care
Sanitizing and disinfecting commercial kitchens are critical. Inadequate sanitation and disinfection expose customers and businesses to risk. Food handlers must be trained in food safety to understand how, what, and when to clean and disinfect, as well as the risks of improper practices. Frequent and rigorous cleaning and disinfection of certified kitchens help prevent food preparation errors.
The CDC estimates that 48 million Americans get sick each year from contaminated
food and drinks. Partnering with food service departments is vital to prevent foodborne illnesses and maintain a ready care environment. Staff must be vigilant during environmental care rounds in these areas, as food safety impacts everyone, especially those with weakened immune systems.
One often-overlooked aspect is the shipping of supplies. Food service staff must manage the volume of cardboard and shipping containers in their kitchens, as these can harbor unknown contaminants. Shipping containers are exposed to moisture, water, insects, and bacterial growth during their long journeys. Proper food storage and handling protocols are essential to prevent contamination.
With the increasing demand for food and beverages, the risk of cross-contamination rises. The food service department's variety of options, stations, tools, and surfaces for preparation and service makes bacterial contaminants like Salmonella, Norovirus, and Hepatitis A common pathogens. Preventing these requires disinfecting surfaces with hospital-approved disinfectants before and after meal preparation. Studies show that washing hands with soap and water reduces diarrhea caused by Shigella and other agents by up to 35%. Partnering with management to ensure easy access to gloves and handwashing stations promotes hand hygiene.
IMPORTANCE OF A CLEAN KITCHEN FOR HOSPITAL SERVICE
Maintaining sanitized kitchen equipment in hospitals is crucial for several reasons: Infection Prevention: Hospitals house patients with weakened immune systems. Contaminated kitchen equipment or food can harbor harmful bacteria, viruses, and other pathogens, leading to infections among patients, staff, and visitors.
Patient Safety: Patients in hospitals are often in poor health, making them more susceptible to infections. Unsafe meals can cause foodborne illnesses and other health complications, jeopardizing patient safety and recovery.
Cross-Contamination: Improperly sanitized kitchen equipment can lead to cross-contamination, transferring pathogens from food or surfaces to readyto-eat meals, resulting in foodborne illnesses and health issues.
Regulatory Compliance: Healthcare facilities, including hospital kitchens, must adhere to strict hygiene and infection control regulations. Maintaining sanitized kitchen equipment is essential for compliance and ensuring the overall quality of patient care. Additional factors include maintaining reputation, reducing healthcare costs, and upholding ethical responsibilities.
Future Outlook and Hotel Model
In summary, keeping hospital kitchen equipment clean is vital for infection prevention, patient safety, regulatory compliance, and maintaining the overall quality of care provided by healthcare facilities. Food safety and hygiene in hospitals require meticulous attention and strict precautions to minimize the risk of foodborne illnesses. Hospital food service is about more than flavor; patients rely on food and beverages as part of their recovery process, making meal times crucial for their overall health plan. Simultaneously, taste and quality significantly impact patients' meal experiences and contribute to healthcare satisfaction ratings.
While cleanliness is vital for both hospitals and hotels, as both cater to those seeking comfort, sanitation methods and objectives still vary. The aesthetic appeal and infection control are both important, but a key factor is establishing a training framework and progress for cleaning staff.
Cleaning is not as simple as it seems; various methods for wiping surfaces, dusting, and disinfecting are necessary for proper usage. Currently, an all-encompassing approach is used alongside expected aesthetic commitments. A paradigm shift towards clinically risk-based practices and the educational foundation for implementation is required.
The first step might be expanding guidelines and policies from basic surface cleaning in hospitals to specialized cleaning tasks like clinical and electrical equipment, cleaning rooms, and high-level isolation units. Establishing global surface cleanliness standards would undoubtedly help focus on what cleaning involves and its effects. Standard operating procedures should reflect the type of hospital, unit, patient vulnerability, and infection risks. The work should include evidencebased standards, routine cleaning practices, cleaning products, sampling methods, and laboratory processes. Each institution should determine the appropriate cleanliness level for its patients, with long-term monitoring to track the biological burden and trends.
Hotel cleaning protocols play a significant role in enhancing staff productivity by providing clear expectations while prioritizing guest health and safety. Room cleanliness greatly contributes to guest satisfaction and positive reviews. Hotel cleaning protocols ensure cleanliness and guest satisfaction, covering various hotel areas (common spaces, dining areas, guest rooms, and back offices) and specifying how to clean and maintain them regularly.
Adopting hotel cleaning protocols is crucial for creating a safe and welcoming environment for guests, protecting brand reputation, and meeting health and safety standards to avoid penalties. Hospitals and hotels share many common factors, making it beneficial for one to learn from the other's experiences. Both are constantly open to large groups, increasing infection transmission risks, making proper sanitation essential. Both seek patient comfort and satisfaction, and both serve large quantities of food, increasing exposure to contaminants.
Maintaining a spotless reputation and positive impressions is critical for both. Therefore, a set of protocols facilitates easier training and education on cleaning practices based on health and safety requirements, with regular audits to ensure compliance.
Organ transplantation with advanced technology!
Physician-Robot cooperation yields big gains!
ROBOTIC ERA IN ORGAN TRANSPLANTATION!
In recent years, rapid developments in both medicine and technology in Turkey have led to the introduction of brand new applications in surgical techniques, one of which is robotic surgery. Stating that robotic surgery is also used in organ transplantation today, Acıbadem University Atakent Hospital Organ Transplant Center Supervisor Prof. Dr. Hamdi Karakayalı emphasizes that this provides very important gains to both the patient, the donor and the surgeon performing the organ transplantation. Prof. Dr. Hamdi Karakayalı made important statements about the point reached in organ transplantation and robotic organ transplantation performed with advanced technology.
THE DEVELOPMENTS IN THE FIELD OF MEDICINE IN TURKEY AND THE STUNNING ADVANCES IN TECHNOLOGY ADDED TO THE EXPERIENCE OF PHYSICIANS HAVE BROUGHT INNOVATIONS IN SURGICAL TECHNIQUES IN RECENT YEARS THAT WERE UNIMAGINABLE IN THE PAST.
Some are reborn, some hold on to life with their new face, legs and arms. According to data released by the Ministry of Health in November last year, 24,449 patients are on the waiting lists for kidney transplantation, 2,600 for liver transplantation, 1,422 for heart transplantation, 277 for pancreas transplantation, 204 for lung transplantation and 4,119 for cornea transplantation, hoping to 'return to life' and regain their health with a donated organ. While Turkey is progressing slowly in cadaveric organ donation, it is at the top of the world list in living donor organ transplantation. Acıbadem University Atakent Hospital Organ Transplant Center Supervisor Prof. Dr. Hamdi Karakayalı states: “Turkey is one of the most experienced countries in the world regarding living donor organ transplants, for this reason, many patients from abroad come to our country to access this treatment opportunity, and physicians from many countries of the world come to our country and our organ transplant centers for training purposes to observe and learn these surgeries. Turkey is becoming more and more preferred not only because it has the most experienced physicians but also because
it has hospitals with excellent infrastructure and equipment using the latest technological developments.”
Advanced technology added to medical experience!
The developments in the field of medicine in Turkey and the stunning advances in technology added to the experience of physicians have brought innovations in surgical techniques in recent years that were unimaginable in the past. Emphasizing that today, even extremely difficult and complex surgeries can be performed in much shorter periods of time, with less bleeding risk, much safer for the patient and more comfortable for the surgeon, and much better results can be obtained, Prof. Dr. Karakayalı explains: “For example, laparoscopic (closed) surgeries have become a routine procedure in organ transplants, especially in kidney donor surgeries, for almost 20 years, resulting in
THE DEVELOPMENTS IN THE FIELD OF MEDICINE IN TURKEY AND THE STUNNING ADVANCES IN TECHNOLOGY ADDED TO THE EXPERIENCE OF PHYSICIANS HAVE BROUGHT INNOVATIONS IN SURGICAL TECHNIQUES IN RECENT YEARS THAT WERE UNIMAGINABLE IN THE PAST
This was the news a total of 30 grandchildren were waiting for! A BOND FORMED BY KIDNEY EXCHANGE BETWEEN TÜRKIYE AND BULGARIA
Emin family from Bulgaria and Erik family from Van city in Türkiye experienced a life-changing event through a paired kidney exchange, facilitated by Professor Hamdi Karakayalı at Acıbadem Hospital in Istanbul. Both families faced chronic kidney failure, but when no suitable donors were found locally, a cross-border solution was achieved. The operation, which used a minimally invasive approach, allowed quick recovery and high success rates, bringing immense joy and improved quality of life to both families. Professor Karakayalı emphasized the importance of kidney transplantation as the definitive treatment for chronic kidney failure and highlighted the rising number of patients opting for treatment in Türkiye due to its advanced medical capabilities.
shorter hospital stays, less pain and better cosmetic results for kidney donors. As a result of the advantages of this method in organ transplants as well as in other surgeries, kidney transplant recipient surgeries in some selected patients, and recently even liver transplant donor surgeries have started to be performed with the closed method. Thanks to increasing experience and constantly developing technology, this method is becoming applicable in liver transplant recipient surgeries as well.”
Robotic surgery has come to the fore in recent years
Stating that one of the most important technological developments in the field of medicine in recent years is the introduction of robotic surgery, Prof. Dr. Hamdi Karakayalı adds, “Robotic surgery, which is widely used especially in urological, gynecological and gastrointestinal system surgeries, has started to take its place in organ transplantation. Although the increase in cost is an important limiting factor, it should be emphasized that it has significant advantages compared to laparoscopic surgery.”
Three-dimensional image instead of two
ROBOTIC SURGERY DOES NOT NECESSARILY MEAN THAT THE SURGERY IS PERFORMED ONLY BY THE ROBOT. THE ARMS OF THE ROBOT ONLY PERFORM THE MOVEMENTS OF THE SURGEON USING IT.
So what are the differences of organ transplantation with robotic surgery from laparoscopic surgery?
Organ Transplant Center Supervisor Prof. Dr. Karakayalı summarizes these differences: “In laparoscopic surgery, the surgeon performs the operation with the help of a camera and instruments inserted into the abdomen, accompanied by a 2-dimensional image; in robotic surgery, the operation is performed with a 3-dimensional and more magnified high-resolution image. Here, the mobility of the surgical instruments placed in the abdomen is much higher, making it easier to perform the surgery in a controlled and safe manner.”
Great benefits for the recipient, the donor and the surgeon
Robotic surgery does not necessarily mean that the surgery is performed only by the robot. The arms of the robot only perform the
movements of the surgeon using it. The use of all these technological developments in the field of medicine, especially in surgery, has only one purpose; to perform an operation that is safer, with fewer complications and less risk of bleeding! In this way, the patient's hospital stay is shortened, the patient feels less pain, the surgical incisions are much smaller and the patient can return to work and social life earlier.
Prof. Dr. Karakayalı says, “On the other hand, since the organ is removed from the donor without any damage, it starts to function immediately when transplanted to the recipient, and the recipient's recovery process is smooth and shorter.”
IN LAPAROSCOPIC SURGERY, THE SURGEON PERFORMS THE OPERATION WITH THE HELP OF A CAMERA AND INSTRUMENTS INSERTED INTO THE ABDOMEN, ACCOMPANIED BY A 2-DIMENSIONAL IMAGE; IN ROBOTIC SURGERY, THE OPERATION IS PERFORMED WITH A 3-DIMENSIONAL AND MORE MAGNIFIED HIGHRESOLUTION IMAGE. HERE, THE MOBILITY OF THE SURGICAL INSTRUMENTS PLACED IN THE ABDOMEN IS MUCH HIGHER, MAKING IT EASIER TO PERFORM THE SURGERY IN A CONTROLLED AND SAFE MANNER.
UChicago Medicine among the first in the country to offer newly approved sickle cell gene therapies
The University of Chicago Medicine Comer Children’s Hospital will be among the first in the country to offer gene therapy for sickle cell disease in patients 12 years and older, after federal regulators approved two new treatments on December 8, 2023.
Thousands of patients with sickle cell disease experience complications including anemia, vaso-occlusive crises (VOCs), acute chest syndrome (ACS) and strokes. The complications, particularly VOCs, can be painful and frequently require hospitalization. The two new gene ther-
ONE FDA-APPROVED THERAPY ADDS A NEW COPY OF A GENE TO THE PATIENT’S STEM CELLS, SO THEY PRODUCE A FUNCTIONAL FORM OF ADULT HEMOGLOBIN.
apy treatments show promise for eliminating VOCs and other issues associated with sickled hemoglobin and offer an alternative to more traditional bone marrow transplants, where patients receive stem cells from another person.
“I'm excited on behalf of our patient population — our patients deserve cutting-edge therapies,” said James LaBelle, MD, PhD, Director of the Pediatric Stem Cell and Cellular Therapy program at UChicago Medicine and Comer Children’s Hospital. “The results of gene therapies are very promising and carry the hope of being definitive and long-lasting, unlike a drug someone might have to take daily for the rest of their life. And since these treatments are based on a patient’s own stem cells, every patient with sickle cell disease has a readily available stem cell donor: themself.”
How
do these new sickle cell gene therapies work?
People with sickle cell disease have a gene mutation that causes their blood cells to produce faulty hemoglobin — a protein that carries oxygen throughout the body — and function incorrectly. Gene therapy uses gene editing technology to fix or compensate for this mutation. Both of the newly approved gene therapies involve removing a patient’s own stem cells and modifying them before infusing them back into the patient. One FDA-approved therapy adds a new copy of a gene to the patient’s stem cells, so they produce a functional form of adult hemoglobin.
The other therapy, which helps patients produce a healthy form of fetal hemoglobin in place of unhealthy adult hemoglobin, is the first FDA-approved product to use CRISPR-Cas9 gene editing technology. Fetal hemoglobin, a form of hemoglobin that every person produces in utero and right after being born, does not sickle and carries oxygen normally. The CRISPR-based gene therapy changes existing DNA in the patient’s stem cells to inhibit a specific protein. That protein normally prevents the production of fetal hemoglobin and turns on the production of non-functional adult hemoglobin affected by sickle cell mutations, so inhibiting the protein reverses those effects.
“One of the reasons scientists are excited
about CRISPR-Cas9 gene therapy products is that they’re highly targeted and don’t contain any foreign DNA,” LaBelle said. “These properties can potentially make these kind of treatments more targeted.”
Comer Children’s was one of the first nine authorized treatment centers immediately activated for the CRISPR-based sickle cell gene therapy upon FDA approval. UChicago Medicine expects to begin treating patients in the first quarter of 2024.
Gene therapy at UChicago Medicine
Physicians and researchers at UChicago Medicine are no strangers to cell and gene therapies. For example, UChicago Medicine was on the leading edge of CAR T-cell therapy research and clinical implementation in 2017 and surrounding years. Comer Children’s Hospital experts even have specific experience administering these therapies to sickle cell patients after the hospital served as a site for a recently published clinical trial of a sickle cell gene therapy.
LaBelle and his colleagues also anticipate more gene therapies to receive regulatory approval in the near future, and they hope to host more clinical trials and lead early clinical implementation.
“As an academic medical center, we are poised to provide new gene therapies to our patients as they are approved while also undertaking the scientific research to understand more about long-term effects — both physical and psychosocial,” LaBelle said.
People across the university are continuing to build the clinical infrastructure needed to support complex therapeutic regimens and treat complex patients while maintaining seamless integration between departments and healthcare teams.
“We're working hard to develop a comprehensive clinic that will not only treat patients with sickle cell disease with gene therapy but also follow them long term and provide ongoing care, including addressing any complications,” LaBelle said. “It’s important that patients are able to access gene therapy without giving up their trusted hematologists and primary physicians.”
James LaBelle, MD, PhD Associate Professor of Pediatrics Director, Pediatric Stem Cell and Cellular Therapy Program
James Labelle, MD, PhD, provides care for children of all ages with cancer and blood diseases, including leukemia and lymphoma.
In particular, Dr. LaBelle specializes in stem cell transplantation, replacing a patient's diseased bone marrow and immune system with healthy cells.
Obesity: Surgery and Treatment Options at
Acıbadem Healthcare Group
Obesity is a growing health problem today. Obesity is associated with many health risk factors and can seriously affect quality of life. At Acıbadem Healthcare Group, we offer obesity surgery and various treatment options as an important step in the fight against obesity.
Bariatric Surgery: A Solution
Obesity surgery is a treatment option that involves surgical procedures to promote weight loss in individuals with morbid obesity. Such surgical procedures aim to manage obesity through methods such as reducing the volume of the stomach or bypassing the intestines.
The degree of obesity is determined by a measure called body mass index (BMI). BMI is calculated by dividing a person's weight in kilograms by the square of their height in meters. People with a BMI over 30 are considered obese, and those over 40 are considered morbidly obese. These people cannot lose weight through diet, exercise, and medication. They also have other serious health risks such as heart disease, diabetes, high blood pressure, and sleep apnea. Morbidly obese people experience emotional difficulties as well as physical difficulties. As a result, treating obesity often requires serious interventions such as bariatric surgery.
OBESITY SURGERY IS A TREATMENT OPTION THAT INVOLVES SURGICAL PROCEDURES TO PROMOTE WEIGHT LOSS IN INDIVIDUALS WITH MORBID OBESITY.
Acıbadem Healthcare Group has experienced surgical teams that specialize in bariatric surgery. These surgical procedures are personalized according to the patient's health status and needs. Obesity surgery procedures offered at Acıbadem include gastric bypass, sleeve gastrectomy, and endoscopic or swallowable gastric balloon. These surgical procedures promote weight loss through various mechanisms and reduce obesity-related health problems.
Obesity Operation Types
Gastric Bypass is an important type of bariatric surgery. In this procedure, the upper part of the stomach is divided to form a small pouch, and the lower part of this pouch is connected directly to the lower parts of the intestines. In this way, some of the food eaten goes into the small pouch of the stomach and bypasses part of the intestine, speeding up the digestion process. As a result, the amount of food ingested is reduced and the number of calories absorbed by the body is reduced. Gastric bypass is considered an effective way to treat obesity-related health problems. It is often preferred when other weight loss efforts have failed or when there are serious obesityrelated health risks.
Gastric Sleeve Surgery is a common method of treating obesity. In this procedure, the stomach is greatly reduced in size and turned into a longitudinal tube. This reduces the amount of food that can be taken in and makes the person feel full more quickly. Gastric sleeve surgery is preferred for individuals who have failed other weight loss methods or who have serious health problems related to obesity. This procedure is considered an effective method for permanent weight loss and improvement of obesity-related health problems.
Endoscopic or Swallowable Gastric
Balloons are two of the minimally invasive procedures used to treat obesity. Endoscopic Gastric Balloon uses an inflatable balloon that is inserted into the stomach through
an endoscope. The balloon partially fills the volume of the stomach, increasing the feeling of fullness and causing the person to eat less. This procedure is often used as part of a weight loss program and is removed after a few months. Swallowable Gastric balloon is a capsule-shaped balloon that the person must swallow. When the capsule reaches the stomach, it is filled with a liquid and increases the volume of the stomach, increasing the feeling of fullness. Unlike the endoscopic gastric balloon, the swallowable gastric balloon does not require endoscopy and is a simpler procedure. It can be excreted naturally from the body, so it does not need to be removed. Both procedures can help reduce obesity-related health risks and promote weight loss.
The Process After Bariatric Surgery
After bariatric surgery, patients usually spend 2-4 days in the hospital, depending on
THE DEGREE OF OBESITY IS DETERMINED BY A MEASURE CALLED BODY MASS INDEX (BMI). BMI IS CALCULATED BY DIVIDING A PERSON'S WEIGHT IN KILOGRAMS BY THE SQUARE OF THEIR HEIGHT IN METERS. PEOPLE WITH A BMI OVER 30 ARE CONSIDERED OBESE, AND THOSE OVER 40 ARE CONSIDERED MORBIDLY OBESE.
the surgical technique. Once the sutures heal, they transition to a liquid diet. Laparoscopic surgery minimizes discomfort and is managed with medications. For the first month, a soft, easily digestible diet is recommended. The smaller stomach size and reduced appetite promote satiety with smaller meals, monitored closely by a dietitian. Obesity treatment involves two stages: first, surgery halts and reverses the disease, while the second stage focuses on dietary changes for permanent weight loss, requiring effective adherence to the plan.
Bariatric surgery requires long-term follow-up after surgery. At Acıbadem, a “multidisciplinary approach” is used to monitor the health of patients after surgery and to support weight loss. Nutritionists,
psychologists, and physiotherapists assist patients during the post-operative recovery process. Bariatric surgery can be an effective treatment option for individuals with obesity. Acıbadem Healthcare Group, with its specialized bariatric surgery teams, offers patients the latest technology and safe surgical procedures. A personalized treatment plan is created for each patient and comprehensive support is provided before and after surgery. You can trust Acıbadem in the fight against obesity for a healthy future.
Which bariatric surgery is right for me?
This will be determined during your consultation with our specialist. The type of surgery depends on your degree of obesity, your medical history, and other factors.
What is the success rate for bariatric surgeries?
Acıbadem Healthcare Group, with its experienced surgeons and multidisciplinary team, has high success rates in obesity surgery according to international standards.
Are Bariatric Surgeries Safe?
Bariatric surgeries are generally safe. However, as with any surgical procedure, it is important to consider the risks and benefits carefully.
THESE SURGICAL PROCEDURES ARE PERSONALIZED ACCORDING TO THE PATIENT'S HEALTH STATUS AND NEEDS. OBESITY SURGERY PROCEDURES OFFERED AT ACIBADEM INCLUDE GASTRIC BYPASS, SLEEVE GASTRECTOMY, AND ENDOSCOPIC OR SWALLOWABLE GASTRIC BALLOON. THESE SURGICAL PROCEDURES PROMOTE WEIGHT LOSS THROUGH VARIOUS MECHANISMS AND REDUCE OBESITYRELATED HEALTH PROBLEMS.
Does the weight disappear permanently after the surgeries?
Obesity surgery usually results in permanent weight loss. Successful weight loss and weight maintenance after surgery depend on healthy lifestyle choices and regular follow-up and support after surgery.
Why should you choose bariatric surgery in Turkey?
Choosing bariatric surgery in Turkey offers advantages such as a high standard of health services, affordable cost, experienced surgeons, and tourist opportunities. The high health standards of Acıbadem and the experience of its specialists in their field can be a reassuring option for patients. In addition, Turkey's tourist attractions can turn the treatment process into a pleasant vacation experience.
For free second medical opinion, contact us via: www.acibadembeautycenter.com
Unveiling the World of Plastic Surgery Reversal: Restoring
Confidence and Identity
Dr. Hamdy Al Khatib, Consultant Plastic Surgeon at Al-Ahli Hospital/Qatar
In the realm of cosmetic enhancement, the pursuit of beauty often leads individuals down the path of plastic surgery. Whether it's a nose refinement, breast augmentation, or a facelift, these procedures promise transformative results, aiming to enhance one's appearance and boost self-confidence. However, what happens when the desired outcome turns into a source of dissatisfaction or distress?
Enter plastic surgery reversal—a concept that is gaining traction in the world of aesthetic
medicine. Unlike plastic surgery revisions, which address complications or unsatisfactory outcomes of a procedure, reversal focuses on restoring one's pre-surgery appearance. But what exactly does this entail, and why do individuals seek it?
Defining Plastic Surgery Reversal
Plastic surgery reversal is essentially the "undoing" of a successful cosmetic treatment or procedure. It is distinct from a revision, which typically aims to correct errors or complications arising from a previous surgery. The primary
THE PRIMARY GOAL OF REVERSAL IS TO RETURN THE INDIVIDUAL TO THEIR APPEARANCE PRIOR TO UNDERGOING THE COSMETIC PROCEDURE.
goal of reversal is to return the individual to their appearance prior to undergoing the cosmetic procedure.
Reasons Behind the Reversal
Several factors may prompt someone to consider plastic surgery reversal, each rooted in unique circumstances and personal experiences:
1. Medical Complications:
Despite advancements in surgical techniques and safety protocols, complications can still occur following cosmetic procedures. From infections to tissue damage, these medical issues may necessitate the reversal of the original surgery to mitigate risks and restore optimal health.
2. Psychological or Emotional Concerns:
While physical transformations are often the focus of cosmetic procedures, the psychological and emotional impact cannot be overlooked. It's not uncommon for individuals to experience feelings of dissatisfaction, anxiety, or even depression following a cosmetic surgery, especially if the results fall short of expectations. In such cases, opting for a reversal can alleviate emotional distress and restore peace of mind.
3.
Changes in Personal Preferences:
As time passes, our preferences and perspectives on beauty may evolve. What once seemed desirable may no longer align with our current ideals. For instance, individuals may reconsider the size of breast implants or wish to reclaim ethnic facial features that were altered in a previous procedure. In these instances, a plastic surgery reversal enables individuals to regain a sense of authenticity and identity.
Navigating the Journey
The decision to undergo plastic surgery reversal is deeply personal and requires careful consideration. It's essential for individuals to consult with qualified plastic surgeons who specialize in reversal procedures, as they possess the expertise and experience
necessary to navigate this unique journey. During the consultation process, surgeons will assess the individual's medical history, current concerns, and desired outcomes. They will also discuss the potential risks, benefits, and limitations of the reversal procedure, ensuring that the individual is well informed and prepared for what lies ahead.
From a practical standpoint, the reversal process may involve techniques such as implant removal, tissue reconstruction, or corrective surgeries to restore natural contours and proportions. While the specifics vary depending on the type of procedure and individual circumstances, the overarching goal remains consistent—to help individuals reclaim their sense of self and confidence.
Empowering Authenticity
In a world where societal standards of beauty often dictate perceptions of self-worth, the concept of plastic surgery reversal serves as a beacon of empowerment and authenticity. It acknowledges that beauty is subjective, evolving, and deeply personal—an expression of individual identity rather than a prescribed ideal.
By embracing the possibility of reversal, individuals are granted the freedom to explore, experiment, and redefine their appearance on their own terms. Whether it's correcting a medical complication, alleviating emotional distress, or reclaiming personal preferences, plastic surgery reversal offers a pathway to selfdiscovery and acceptance.
In the journey towards self-enhancement, the pursuit of beauty should always be accompanied by a commitment to self-care, self-love, and self-acceptance. Plastic surgery reversal, with its focus on restoration and rejuvenation, embodies this ethos, reminding us that true beauty transcends the boundaries of cosmetic enhancement—it resides within the depths of authenticity and self-assurance.
FROM A PRACTICAL STANDPOINT, THE REVERSAL PROCESS MAY INVOLVE TECHNIQUES SUCH AS IMPLANT REMOVAL, TISSUE RECONSTRUCTION, OR CORRECTIVE SURGERIES TO RESTORE NATURAL CONTOURS AND PROPORTIONS. WHILE THE SPECIFICS VARY DEPENDING ON THE TYPE OF PROCEDURE AND INDIVIDUAL CIRCUMSTANCES, THE OVERARCHING GOAL REMAINS CONSISTENT—TO HELP INDIVIDUALS RECLAIM THEIR SENSE OF SELF AND CONFIDENCE.
Tell us about yourself? Your specialty? Your philosophy as a surgeon?
I’m Dr. Mohamad Kodeih, I’m a plastic & reconstructive surgeon with 15 years of clinical practice. I’m specialized in body contouring as well as breast surgery. My philosophy concerning surgery is to always provide the best outcome with the least scars in the body. The less invasive the procedure, the less the pain and complications post-surgery and the faster the healing and recovery.
Can you discuss any specializations or areas of expertise within plastic surgery that you're particularly passionate about?
I am deeply passionate about promoting breast health and well-being. I believe in an approach that extends beyond just cosmetic enhancement, focusing on communication with my patients, education, and comprehensive care. By integrating the latest advancements in surgical techniques with a patient-centered approach, I strive to empower individuals to make informed decisions about their breast health, ensuring not only aesthetic satisfaction but also longterm physical and emotional wellness.
How do you stay abreast of emerging techniques and technologies in cosmetic and reconstructive surgery?
Plastic and Reconstructive Surgeon Dr. Mohamad Kodeih
"Mia FemtechTM sets a new standard in breast enhancement"
Mia Femtech™ sets a new standard in breast enhancement, providing women with customizable options that cater to their individual needs and preference. By prioritizing both aesthetic appeal and long-term durability, Mia® sets a new standard in breast enhancement, said Dr. Mohamad Kodeih a plastic & reconstructive surgeon during an exclusive interview with ‘Hospitals’ magazine.
As a plastic surgeon committed to delivering the highest standard of care, I prioritize staying abreast of emerging techniques and technologies in both cosmetic and reconstructive surgery. I regularly attend conferences, engage in continuous education programs, and collaborate with colleagues to exchange insights and experiences. By remaining at the forefront of advancements, I ensure that my patients benefit from the most innovative and effective treatments available, resulting in optimal outcomes and satisfaction.
That’s why I always attend conferences and meetings as well as congresses worldwide in Europe and in the United States, as well as in the Gulf region and my focus is mostly on breast aesthetics and breast reconstruction since this is my area of expertise and passion.
What advancements in technology have had the most significant impact on the field of plastic surgery in recent years?
During the last five years, there has been some innovation in body contouring which brought good advancement in the field of plastic and reconstructive surgery, offering safer, more precise procedures with enhanced results. From minimally invasive techniques like liposuction to advanced technologies such as laser-assisted body sculpting, patients now have many options for achieving their desired
AS A PLASTIC SURGEON COMMITTED TO DELIVERING THE HIGHEST STANDARD OF CARE, I PRIORITIZE STAYING ABREAST OF EMERGING TECHNIQUES AND TECHNOLOGIES IN BOTH COSMETIC AND RECONSTRUCTIVE SURGERY.
aesthetic goals with minimal downtime and optimal outcomes.
As an example, the integration of 3D imaging and virtual reality simulations allows for personalized treatment planning, ensuring that patients have a clear understanding of their potential results before undergoing surgery. With ongoing research and innovation in the field, the future of body contouring continues to hold promise for even more advanced techniques and transformative outcomes. We have a lot of new devices that are based on energy and heat and radiofrequency that provide a lot of skin tightening without having to cut skin in certain cases.
What are some of the latest trends and innovations in breast health that plastic surgeons should be aware of?
Relating to breast surgery there has not been a major innovation in the past 30 years until the recent innovation that we have which is Mia®, that’s the reason that I was so attracted to this procedure because I believe as a plastic surgeon we are the leaders in this aspect of surgery where we need to have minimal scars as well as minimal downtime with the highest precision and best outcomes.
Traditionally, breast augmentation has seen incremental advancements primarily focused on enhancing the safety and longevity of implants such as texturing, shell and core, as well as silicon quality. However, the introduction of Mia® represents a significant breakthrough in breast health.
Explain what Mia® is, its benefits, what makes it so special in terms of technology and technique, what it means to the consumers.
Mia®'s revolutionary approach combines state-of-the-art materials with innovative design, resulting in implants that offer unparalleled natural look and feel. By prioritizing both aesthetic appeal and longterm durability, Mia® sets a new standard in breast enhancement, providing women with customizable options that cater to their individual needs and preferences. I am confident that being the first injectable
implants with improved biocompatibility thanks to its innovative surface, Mia® will be the future of breast enhancement because it is not just about incremental improvements but about transformative innovations that redefine beauty and confidence. For those women who are not yet ready to go under the knife and undergo any major surgery I would say the only innovation or breakthrough recently is Mia®.
So what is Mia®?
Mia® is a minimally invasive procedure to enhance the breast shape and size to be in harmony with the rest of the body. It is performed under local anesthesia with mild sedation where the consumer is awake during the procedure, which lasts around 15 minutes. When a woman goes through the experience, she is in and out of the hospital in 90 minutes. She can then resume her normal daily life the same day. Another breakthrough is the fact that there are no scars on the breast. The scar is a very small inconspicuous scar in the axilla that blends in with the axillary wrinkles and lines. Also the very natural result so we don’t have this fake result that we see with patients undergoing the traditional breast augmentation.
One very important and in my opinion, the most important aspect of the procedure is the fact that it’s a breast preservation procedure which means we never cut any tissues inside the breast per se the ligaments are intact. The veins, arteries and nerves are intact as well as the gland so we just create a space in contrary to the traditional augmentation where we had to dissect a pocket. With Mia® we just create a space where the implant is injected using a special injector.
This aspect carries significant weight for women, particularly in terms of postoperative recovery and resumption of normal activities. Nowadays, many of them maintain demanding professional obligations that necessitate minimal time away from work, in addition to familial responsibilities such as caring for children. In this context, Mia®'s approach offers considerable advantages, facilitating a quicker return to daily routines.
THE INTEGRATION OF 3D IMAGING AND VIRTUAL REALITY SIMULATIONS ALLOWS FOR PERSONALIZED TREATMENT PLANNING, ENSURING THAT PATIENTS HAVE A CLEAR UNDERSTANDING OF THEIR POTENTIAL RESULTS BEFORE UNDERGOING SURGERY. WITH ONGOING RESEARCH AND INNOVATION IN THE FIELD, THE FUTURE OF BODY CONTOURING CONTINUES TO HOLD PROMISE FOR EVEN MORE ADVANCED TECHNIQUES AND TRANSFORMATIVE OUTCOMES
Moreover, compared to conventional augmentation procedures, it reduces postoperative discomfort. Remarkably, the majority of women who went through the Mia® experience have reported experiencing pain levels ranging from one to two on a ten-point scale, underscoring the procedure's efficacy in minimizing discomfort associated with breast surgery. And most importantly the sensation has not changed as well as the fact that they can breastfeed normally and they don’t feel that there’s a foreign body inside their breast so they just feel natural as if they were born with that breast.
So Mia® is currently exclusive to a certain number of surgeons not any surgeon can provide the Mia® procedure and in Lebanon only three surgeons are certified and this is because we underwent very rigorous training and proctorship in Europe, as well as in Lebanon before we were certified to be Mia® providers.
Do you think that minimally invasive is the future of breast aesthetics?
As for the future of plastic surgery and cosmetic surgery and aesthetics, I believe that the future is going in the direction of minimally invasive techniques which Mia® provides. I think in the future we will also see a breakthrough in buttock surgery as well. We can perform buttock implants using also minimal invasive techniques similar to the Mia® procedure and that will be a game changer in the field of aesthetics.
How do you prioritize consumers satisfaction and ensure a positive experience throughout their Mia® procedure journey, from initial consultation to post-procedure care?
Consumer satisfaction is another aspect that is very important to us as surgeons and with the media procedure. This is very much targeted and reached so all the consumers want to go report a very high-level of satisfaction with the result, the procedure, the whole experience, from the moment they step into the car, which is a special Limousine Service that takes them to the hospital and takes them back so they don’t have to worry about driving or having somebody take them. They can come on their own and
the procedure is so calm and so easy that the consumer feels they are not undergoing surgery actually they feel they’re going to the spa and getting treatment for their body like a massage or any other treatment.
Another important aspect about consumer satisfaction is to make sure they know what to expect so we have to explain very well and show them pictures so we focus on very realistic expectations. Consumers have to understand that it’s a very, very natural result.
I have some consumers who testified after the new procedure and they were so happy and satisfied with the result and experience. I have a younger lady, not married yet who works as a pharmacist and a pharmacy company and as she was planning to get married in a couple of months and she was not very happy and confident with the shape and size of her breast so she decided to undergo this procedure, which went great. She results are so natural and so beautiful and in harmony with her body that she is very happy and talking about it to all her friends.
What could be the secret to long-term satisfaction in your practice?
The key to long-term satisfaction in plastic surgery practice lies in understanding that we can never have perfect results, here I would like to say we can never have perfect results.
I always say the next case is better than the previous case but in general, there are certain factors that affect the long-term outcome and satisfaction of our patients. First is to have an individualized approach so every patient is special in its own sense and has to be treated that way we cannot give the same procedure to all consumers.
Every consumer needs a tailor-made approach and surgery that fit her body and her individual needs. Quality also is very important for me. It’s probably the most important, so you need to provide very good quality from A to Z as well as the best environment for the patient. The best implants technique is also very important, that’s why above all innovation is key.. With innovation comes quality, and better techniques which lead to better outcomes and better results.
MIA® IS CURRENTLY EXCLUSIVE TO A CERTAIN NUMBER OF SURGEONS. NOT ANY SURGEON CAN PROVIDE THE MIA® PROCEDURE AND IN LEBANON ONLY THREE SURGEONS ARE CERTIFIED AND THIS IS BECAUSE WE UNDERWENT VERY RIGOROUS TRAINING AND PROCTORSHIP IN EUROPE, AS WELL AS IN LEBANON BEFORE WE WERE CERTIFIED TO BE MIA® PROVIDERS.
Transform Your Smile: The Importance of Cosmetic Dental Treatment
Dr. Sami Krimly, Prosthodontist - Head of Dental Department - Al-Ahli Hospital/Qatar
In today's society, the significance of cosmetic dental treatment has soared to unprecedented heights, driven by various factors including the influence of social media, the essentials of social life, and the importance of physical appearance in both the community and the workplace. Al-Ahli Hospital Dental Center stands out as a beacon of excellence in this realm, offering comprehensive cosmetic and medical treatment plans, cutting-edge technology, and a team of skilled and talented dentists.
The Impact of Social Media
In the age of social media, where images are shared instantaneously and perceptions are formed at a glance, having a beautiful smile has become more crucial than ever.
Social media platforms like Instagram and Facebook are flooded with images of perfect smiles, influencing individuals to seek cosmetic dental treatments to enhance their appearance and boost their confidence.
Essentials of Social Life
A smile is often the first thing people notice about someone, and it plays a vital role in social interactions.
Whether it's meeting new people, attending social events, or engaging in conversations, a confident smile can leave a lasting impression and facilitate positive connections. Cosmetic dental treatments can address imperfections such as stains, crooked teeth, or gaps, helping individuals feel more confident in social settings.
Importance of Physical Appearance:
In today's competitive world, physical appearance carries significant weight, especially in professional environments. A bright, healthy smile not only contributes to one's personal confidence but also enhances their professional image. Studies have shown that individuals with attractive smiles are perceived as more successful, trustworthy, and approachable, making cosmetic dental treatments a valuable investment in one's career advancement.
Why Al-Ahli Hospital Dental Center is Distinguished:
Al-Ahli Hospital Dental Center stands out as a premier destination for cosmetic dental treatments due to several key factors:
Comprehensive Cosmetic & Medical Treatment Plan: At Al-Ahli Hospital Dental Center, emphasis is placed not only on the aesthetic aspect but also on the overall
oral health of patients. The center offers comprehensive treatment plans that address both cosmetic concerns and underlying dental issues, ensuring patients achieve a healthy, dazzling smile.
Advanced Technology: The center is equipped with state-of-the-art technology and innovative dental tools, allowing for precise diagnostics and advanced treatment procedures. From digital smile design software to 3D imaging technology, patients can benefit from the latest advancements in cosmetic dentistry.
Skilled & Talented Dentists: The dental team at Al-Ahli Hospital comprises highly skilled and experienced dentists who specialize in various aspects of cosmetic dentistry. Their expertise, coupled with a commitment to continuing education, ensures that patients receive the highest quality of care and achieve optimal results.
Fully-Fledged Dental Center: Al-Ahli Hospital Dental Center offers a comprehensive range of dental services, encompassing all specialties and subspecialties under one roof. Whether patients require orthodontic treatment, dental implants, or cosmetic veneers, they can access a full spectrum of dental care tailored to their needs.
In conclusion, cosmetic dental treatment has become increasingly important in today's society, driven by the influence of social media, the essentials of social life, and the significance of physical appearance.
Al-Ahli Hospital Dental Center stands at the forefront of cosmetic dentistry, offering comprehensive treatment plans, advanced technology, and a team of skilled dentists dedicated to transforming smiles and enhancing lives.
COSMETIC DENTAL TREATMENT HAS BECOME INCREASINGLY IMPORTANT IN TODAY'S SOCIETY, DRIVEN BY THE INFLUENCE OF SOCIAL MEDIA, THE ESSENTIALS OF SOCIAL LIFE, AND THE SIGNIFICANCE OF PHYSICAL APPEARANCE. AL-AHLI HOSPITAL DENTAL CENTER STANDS AT THE FOREFRONT OF COSMETIC DENTISTRY, OFFERING COMPREHENSIVE TREATMENT PLANS, ADVANCED TECHNOLOGY, AND A TEAM OF SKILLED DENTISTS DEDICATED TO TRANSFORMING SMILES AND ENHANCING LIVES.
Badem Pediatrics Oncology Center
Advanced Treatments for Better Success in Childhood Cancers
Cancer is not just an adult disease, it is also seen in children aged 0 to 18 years. Childhood cancers differ from adults in terms of pathogenesis, progress of illness and treatment. This disease, which anyone, in fact, fails to fit it for children, can be detected early thanks to developing technology and science. With suitable treatment and invention methods, the incidence of death in childhood cancers are gradually decreasing.
According to the data of the World Health Organization, approximately 300.000 children between the ages of 0-19 are diagnosed with cancer every year and an average of 80.000 children die due to cancer. Studies show that the incidence of childhood cancers is increasing every year. While the incidence of childhood
UNDER THE LEAD OF PROFESSOR FUNDA ÇORAPÇIOĞLU, BADEM ONCOLOGY CHILDREN CENTER IS COMMITTED TO PROVIDING EXCEPTIONAL CARE FOR CHILDREN WITH CANCER AND ENSURES THAT EVERY CHILD RECEIVES THE BEST POSSIBLE CARE TAILORED TO THEIR SPECIFIC NEEDS.
cancer is increasing all over the world, the overall survival rate has reached up to 90% today.
July: Bone Cancer and Sarcoma Awareness Month
July is recognized as Bone Cancer and Sarcoma Awareness Month, dedicated to raising awareness about these rare and challenging forms of cancer in children.
BADEM Oncology Children Center, a distinguished part of Acıbadem Maslak Hospital in Istanbul, is a premier facility dedicated to the comprehensive care and treatment of pediatric cancer patients. Known for its cuttingedge technology, compassionate care, and multidisciplinary approach, the center stands at the forefront of pediatric oncology in Turkiye and the region.
Under the lead of Professor Funda Çorapçıoğlu, BADEM Oncology Children Center is committed to providing exceptional care for children with cancer and ensures that every child receives the best possible care tailored to their specific needs.
Acıbadem Health Group Pediatric Oncologist Professor Funda Çorapçıoğlu, who has valuable studies on childhood cancers and has been treating children for years, has stated that childhood cancers are much more different
from adult cancers in terms of incidence and symptoms. Moreover, Çorapçıoğlu added that progress of childhood cancer can be more complicated than adults’ and the treatment and follow-up of children can take a long time. At this point, Acıbadem Healthcare Group in Turkiye provides all kinds of support to make the clinics of children with cancer more comfortable so that the children feel like themselves as at their own home. A pediatric clinic called “Badem” was established inside Acıbadem Maslak Hospital in Istanbul, where only children with cancer are treated. Children consider this place for treatment as their own home during the healing process and follow-up. Thus, kids can successfully complete their treatment in an environment where they can say “This is my place”.
Sarcoma is the name given to cancers that develop in soft tissues such as muscles, connective tissue, nerves and adipose tissue. It is common in childhood. Pediatric Oncology Specialist Professor Funda Çorapçıoğlu says that infantile fibrosarcoma is the most common soft tissue cancer under 1 year old, and
SARCOMA IS THE NAME GIVEN TO CANCERS THAT DEVELOP IN SOFT TISSUES SUCH AS MUSCLES, CONNECTIVE TISSUE, NERVES AND ADIPOSE TISSUE. IT IS COMMON IN CHILDHOOD.
rhabdomyosarcoma is most common in children over 1 year old. She adds that these cancers, the cause of which is unknown, may be caused by genetic changes.
When Dimana was only six months old, a swelling was detected in her palm in Bulgaria, which was later diagnosed as "sarcoma." Despite treatments in her country, the swelling continued to grow. Pediatric Oncology Specialist Funda Çorapçıoğlu explained that such rapid growth is typical in infantile fibrosarcoma due to fast cell division. By the time she sought help from Acıbadem Healthcare Group, the tumor had grown so large that it caused compartment syndrome, severely affecting her hand's nerves and vessels, leading to bruising and numbness.
Dimana was then evaluated by the experienced team at BADEM Pediatrics Oncology Center. Chemotherapy was administered to shrink the tumor, preventing further damage and allowing for surgical removal. The tumor was completely removed by a specialized orthopedist, and chemotherapy
continued post-surgery to minimize recurrence risk. Dimana has recovered well and continues her follow-ups. Professor Çorapçıoğlu highlighted the importance of the first five years of follow-up for her type of cancer and noted that chemotherapy was crucial in ensuring the tumor did not spread further.
New drugs and new treatments have emerged in recent years. The aim of these treatments is to reduce the side effects of classical chemotherapy by targeting the tumor tissue as much as possible. However, none of these are miracles on their own. In addition, these new treatments may not be applicable to all tumors. Before starting treatment, it should be determined whether the tumor will be eliminated with the help of drugs or not.
Immunotherapy, one of the newly developed treatment methods, is a type of treatment that allows the immune system to fight cancer cells. There are many different types such as T cell transfer, Monoclonal Antibody,
DIMANA WAS THEN EVALUATED BY THE EXPERIENCED TEAM AT BADEM PEDIATRICS ONCOLOGY CENTER. CHEMOTHERAPY WAS ADMINISTERED TO SHRINK THE TUMOR, PREVENTING FURTHER DAMAGE AND ALLOWING FOR SURGICAL REMOVAL. THE TUMOR WAS COMPLETELY REMOVED BY A SPECIALIZED ORTHOPEDIST, AND CHEMOTHERAPY CONTINUED POST-SURGERY TO MINIMIZE RECURRENCE RISK. DIMANA HAS RECOVERED WELL AND CONTINUES HER FOLLOWUPS. PROFESSOR ÇORAPÇIOĞLU HIGHLIGHTED THE IMPORTANCE OF THE FIRST FIVE YEARS OF FOLLOWUP FOR HER TYPE OF CANCER AND NOTED THAT CHEMOTHERAPY WAS CRUCIAL IN ENSURING THE TUMOR DID NOT SPREAD FURTHER.
oncolytic viruses etc. The Pediatric Oncologist decides which type of immunotherapy will be applied to which tumor.
The drugs used in classical chemotherapy can be given to the body up to a certain dose. When these doses are exceeded, the body is not able to stand it. Thanks to stem cell transplantation, it is possible to give highdose chemotherapy. The success rate of this treatment varies according to the type and stage of the disease, the characteristics of the stem cell donor and the type of transplantation.
Targeted therapies, also known as smart molecules, which are important in cancer treatment, also have an important place in the treatment of childhood cancers. The drugs used for this treatment are specially prepared in the laboratory by detecting the characteristics of the tumor cell. When given to the body, they go and find the tumor tissue. Then, they either destroy this tissue directly, or they surround that tissue and call other cancer-fighting inflammatory cells, enabling these warrior cells to fight the tumor.
Çorapçıoğlu stated that the tumor must be defined before application of treatment. She clarified that for this, advanced techniques should be studied in a comprehensive laboratory. “It is necessary to find the passport number of the tumor. We need to detect this and send medicine accordingly. In this way, healthy cells live, but only cancerous cells die. We are doing
very good work on these treatments," she said.
Success in childhood cancers has increased considerably in recent years. Thanks to the developing technology, the tumor can now be better differentiated from the normal tissue. The use of drugs that are effective only on tumor tissue and eliminates side effects. At the same time, it provides a complete treatment by destroying the target tumor tissue.
Professor Funda Çorapçıoğlu does not relate the success in the treatment of childhood cancers as with simply eliminating the disease. She states that success should be measured by reintegrating these children into society as individuals when their treatment is over. Therefore, it should be ensured that the preferred treatment for pediatric patients is chosen in a way that will cause the least harm to them both physically and mentally in the future.
As Acıbadem Healthcare Group, we aim not only to eradicate the disease in childhood cancers, but also to treat our patients in a way that they can live more comfortably for the rest of their lives. What makes us happy is to make them feel at home during the long and difficult process and to see the clinics where they are treated as their own place and to make them say "this is my place" instead of "hospital".
A PEDIATRIC CLINIC CALLED “BADEM” WAS ESTABLISHED INSIDE ACIBADEM MASLAK HOSPITAL IN ISTANBUL, WHERE ONLY CHILDREN WITH CANCER ARE TREATED. CHILDREN CONSIDER THIS PLACE FOR TREATMENT AS THEIR OWN HOME DURING THE HEALING PROCESS AND FOLLOW-UP. THUS, KIDS CAN SUCCESSFULLY COMPLETE THEIR TREATMENT IN AN ENVIRONMENT WHERE THEY CAN SAY “THIS IS MY PLACE”.
Cedars-Sinai Secures Global Healthcare
Accreditation for a Second Time
Recognition Reinforces Cedars-Sinai International’s Ongoing Mission to Improve Healthcare
Cedars-Sinai Medical Center has earned an accreditation for Medical Travel Services by Global Healthcare Accreditation (GHA). This is the second time that Cedars-Sinai has been recognized among the top-notch hospitals providing international patients with the highest-quality healthcare in the United States.
CEDARS-SINAI PROVIDES HIGHLY INTEGRATIVE DIAGNOSTICS, TREATMENTS AND PROCEDURES FOR PATIENTS WITH COMPLEX MEDICAL CONDITIONS.
Cedars-Sinai is a leading nonprofit academic healthcare organization serving the diverse Los Angeles community and more than 2,000 patients from over 100 countries each year. U.S. News & World Report has named Cedars-Sinai to the Honor Roll for the eighth consecutive year in its “Best Hospitals 2023-24” rankings.
With more than 4,500 physicians and nurses, 1,500 research projects in motion, stateof-the-art facilities and advanced technology, Cedars-Sinai provides highly integrative diagnostics, treatments and procedures for patients with complex medical conditions.
GHA’s latest international standards for medical travel have been developed in consultation with leading global experts in the industry and are accredited by the International Society for Quality in Health Care External Evaluation Association (ISQua EEA). The GHA accreditation seal builds trust by demonstrating that Cedars-Sinai has implemented procedures and policies to mitigate risks and enhance the patient experience across each step of the medical travel journey.
"Cedars-Sinai's unique combination of leading-edge research, world-class medical education, and exceptional patient care has established us as a global healthcare leader. Our multidisciplinary approach allows us to provide comprehensive, tailored care to patients from our local community and those who travel from around the world,” said Heitham Hassoun, MD, Chief Executive of Cedars-Sinai International.
“Achieving GHA re-accreditation is a testament to our ongoing efforts to improve the medical traveler experience, inspiring us to further streamline processes and enhance services."
As part of the accreditation process, GHA representatives conducted a three-day survey of the Cedars-Sinai International offices. During the visit, the surveyors interviewed staff and patients and inspected healthcare treatment areas. Additionally, the representatives assessed guidelines and standards of care in key areas, such as cultural competency, patient advocacy
Heitham Hassoun, MD., Chief Executive of Cedars-Sinai International
and safety, leadership, marketing communications and business ethics in addition to a variety of other health-related measures.
"In today's global healthcare landscape, patients have more choices than ever. GHA accreditation helps distinguish healthcare providers who go above and beyond in catering to the unique needs of medical travelers,” said GHA Chief Executive Officer Renée-Marie Stephano “Cedars-Sinai's re-accreditation underscores its unwavering commitment to providing exceptional care, ensuring patient safety and creating a supportive environment for international patients. GHA congratulates Cedars-Sinai on this outstanding achievement."
THE GHA ACCREDITATION SEAL BUILDS TRUST BY DEMONSTRATING THAT CEDARS-SINAI HAS IMPLEMENTED PROCEDURES AND POLICIES TO MITIGATE RISKS AND ENHANCE THE PATIENT EXPERIENCE ACROSS EACH STEP OF THE MEDICAL TRAVEL JOURNEY.
Liv Hospital Digital transformation in health
3D Imaging And Virtual Reality
"By converting preoperative radiological tests into digital models and matching these models with the patient's real body in a virtual environment, operation planning and the operation process are more successful", Liv Hospital Brain and Nerve Surgery Physicians Çağrı Canbolat, MD and Assoc. Prof. Dr. Abuzer Güngör, MD explained.
Imaging And Modeling
The detailed planning process is carried out before the operation is critical for the patient's health and the success of the operation. In this process, advanced imaging techniques such as MRI and CT are used. The MRI imaging method provides detailed images of soft tissues such as the brain, while CT scans reveal bone and other tissues more clearly. For example, with brain tumor operation, MRI scans help physicians determine the location of the tumor in the brain tissue. CT angiography and MRI angiography, on the other hand, play a critical role by providing detailed images of blood vessels, especially in the operations of cerebrovascular diseases.
The high-resolution images provided by these imaging techniques enable the creation of detailed digital models of the patient's tissues and anatomical structures. These models are specific to the patient's personal anatomy and offer the physician unique guidance with surgical planning. In this way, a personalized surgical approach can be developed for each patient.
3D Scanning And Matching
The patient's head structure is transformed into a digital model using 3D scanning technologies. This process allows creating a three-dimensional copy of the patient's anatomical structure, thus obtaining a model closest to the real structure that will be encountered during the operation. For example, in the case of a head injury, the model obtained by 3D scanning can be matched with the digital model obtained by
radiological tests to clearly exhibit the fractured or damaged regions. The matching process ensures an accurate match between the real and digital images and provides a solid basis for our operation planning. Thanks to this integration, difficulties that may be encountered during operation can be predicted and strategies can be planned accordingly.
Virtual Reality And Simulation
Virtual reality (VR) technology welcomes a new era in surgical training and planning. By simulating the matched images in a VR environment, a realistic experience is obtained before the operation. Especially in complex surgical interventions, these simulations offer us the opportunity to gain critical experience before the real operation.
For example, during a brain operation simulation, the procedures we perform in the virtual environment ensure that we are prepared for the difficulties that will be encountered during the real operation.
Thanks to VR simulations, the region where the operation will be performed can be evaluated in three dimensions and various surgical strategies can be tested. These simulations play a major role, especially with the training of
THE DETAILED PLANNING PROCESS IS CARRIED OUT BEFORE THE OPERATION IS CRITICAL FOR THE PATIENT'S HEALTH AND THE SUCCESS OF THE OPERATION. IN THIS PROCESS, ADVANCED IMAGING TECHNIQUES SUCH AS MRI AND CT ARE USED. THE MRI IMAGING METHOD PROVIDES DETAILED IMAGES OF SOFT TISSUES SUCH AS THE BRAIN, WHILE CT SCANS REVEAL BONE AND OTHER TISSUES MORE CLEARLY.
young surgeons because they are able to gain experience in a virtual environment before practicing on real patients.
Application In The Operating Room And Augmented Reality
During operation, planned procedures can be performed using 3D models and augmented reality (AR) technology. This technology provides a better understanding of the operation site by placing digital information on the actual anatomical structure of the patient.For example, in a tumor operation, thanks to AR technology, the exact location of the tumor and the surrounding intact tissues can be clearly observed. This ensures complete removal of the tumor and preservation of healthy tissues.
This technological approach allows for less
Liv Academy
Liv Hospital transcends geographical limitations, facilitating international partnerships and fostering a community of lifelong learners. With a dedication to ethical practice, technological innovation, and patient-centered care, we strive to uphold the highest standards of excellence in healthcare delivery.
Liv Academy opens its doors to physicians, healthcare professionals, and aspiring medical experts from around the world with a steadfast commitment to advancing medical knowledge and fostering cross-cultural exchange.
Building The Future Of Healthcare
Discover the future of healthcare education with Liv Academy, where training transcends boundaries, merging online and physical platforms to unite medical students, healthcare personnels and physicians.
Delve into the realms of medical theory alongside esteemed experts, participate in sur-
invasive procedures to be performed during operations and therefore accelerates the patient's recovery process. In addition, it ensures that operations are safer and more effective by minimizing surgical errors. The use of augmented reality technology saves time and cost in surgical processes, while also increasing satisfaction and safety of the patient.
This technological integration in healthcare leads to higher success rates and fewer risk factors before and during operation. This approach, which offers a safer and more effective operation experience for patients and surgeons, has an important place in the future of modern medicine. We believe that with the development and dissemination of these technologies, the revolutionary change in the field of medicine will continue.
gical observations, and explore a diverse array of healthcare specialties.
Follow The Latest In Healthcare
Stay abreast of the ever-evolving healthcare landscape by staying informed with Liv Academy. Gain exclusive access to a plethora of webinars and symposiums hosted by Liv Hospital, offering insights into cutting-edge treatments and groundbreaking technologies that shape the future of healthcare globally.
Personalized Training In Every Discipline
At Liv Academy, we prioritize personalized learning experiences tailored to meet the unique demands of individuals and institutions alike. Our comprehensive training programs cover a spectrum of specialties, ensuring that participants are equipped with the latest approaches, treatment modalities, and technological advancements in their respective fields.
AT LIV ACADEMY, WE PRIORITIZE PERSONALIZED LEARNING EXPERIENCES TAILORED TO MEET THE UNIQUE DEMANDS OF INDIVIDUALS AND INSTITUTIONS ALIKE.
An AI-Driven Dream: Towards Emirates Health Service's Vision of Sustainable Healthcare
Her
Mr.
Excellency
Mubaraka Ibrahim - Acting CIO, Emirates Health Services
Sooraj Pilankuveedu - Director, Oracle Health
In the pursuit of sustainable development goals, the global healthcare sector stands at a critical point, grappling with the pressing issue of massive carbon emissions contributed as a result of healthcare-related activities. The healthcare industry is estimated to contribute to greater than 4% of global carbon emissions, translating into approximately 1.48 billion metric tonnes annually.
Demonstrating a steadfast dedication to sustainable development goals, the United Arab Emirates officially designated 2023 as the "Year of Sustainability." This announcement underscored the nation's unwavering commitment to fostering a sustainable future. The journey towards the visionary goal of "today for tomorrow" has been marked by years of concerted efforts on a national scale. The ambitious endeavor involves reducing carbon emissions and elevating the reliance on renewable energy sources to shape a more environmentally conscious and resilient future.
Emirates Health Services (EHS) is fully aligned with the nation's vision, and they have sketched a clear roadmap to monitor sustainability progress and accelerated alignment with the national goals. As it progresses towards the highly anticipated COP28, they are geared to implement and enhance initiatives that make healthcare service environment-friendly without compromising the quality of care.
Emirates Health Services caters to the healthcare needs of a vast majority of the UAE population through widespread network of facilities, making it one of the key contributors to the country's healthcare sector. They focus
on the global health goal (SDG-3) of 'ensuring healthy lives and promoting well-being for all ages’ by leveraging the Oracle Electronic Health Record (EHR) system. Employing the EHR’s capabilities to pioneer the latest technologies like Artificial Intelligence coupled with telemedicine, they are accelerating towards its aim of reducing the carbon footprint of our healthcare services.
In its endeavours to promote sustainable practices through innovation in the field of healthcare, Emirates Health Services introduced a data-driven, artificial intelligence-based Healthcare Sustainability initiative. This initiative is conceived as a promise to its current and future generations for a cleaner environment today and tomorrow. EHS’ use of the Oracle
EMIRATES HEALTH SERVICES CATERS TO THE HEALTHCARE NEEDS OF A VAST MAJORITY OF THE UAE POPULATION THROUGH WIDESPREAD NETWORK OF FACILITIES, MAKING IT ONE OF THE KEY CONTRIBUTORS TO THE COUNTRY'S HEALTHCARE SECTOR.
EHR acts as the hub of all data captured for all activities occurring across the network, and it works as a pivot to project this data to be leveraged for evidence-based practice.
Considering the intricate complexities of clinical visit dynamics, EHS has focused on creating practical solutions introduced in well-planned phases. They followed a logical sequence of several projects under this initiative guided by evidence and statistics from our healthcare network.
As the groundbreaking of our initiative, EHS started the journey towards reduced carbon emissions in the pandemic era when they embraced digital platforms and introduced teleconsultation. This was a mandatory step to ensure safe patient care amidst the lockdown. Supported by simplistic and user-friendly technologies, this service is convenient for patients and helps ensure improved continuity of care for our long-term patients. Patients can opt to seek care from their comfort zones through this facility.
Further in this journey, leadership is committed to continuous improvement, led by evaluating the extent of its problem and assess opportunities for further enhancements. It was agreed that EHS requires crisp insights into the burden of our carbon footprint and related dynamics. They used EHR data to create a carbon emissions simulation dashboard that utilizes standard definitions to benchmark daily carbon emissions per facility. This real-time, state-of-the-art simulator is closely monitored by a dedicated team to identify high-emission clinics and services. It guides their team in identifying problem zones and planning strategies for focused interventions.
As an outcome of its ongoing monitoring and evaluation, and keeping abreast with the latest technologies, EHS leadership agreed that the teleconsultation services must be augmented further to reduce the emissions caused by patient commutes and devised two initiatives to achieve this phase of augmentation.
First, the experience of teleconsultation has been enhanced by the introduction of
metaverse technology for teleconsultation service. The Oracle EHR system seamlessly integrates with metaverse technology to deliver patients a cohesive experience. This groundbreaking integration provides patients with a unique and immersive encounter, enabling them to virtually engage with a clinical setting right from the comfort of their homes. The global popularity of the metaverse is on the rise, particularly for certain well-defined use cases. There is conclusive evidence that metaverse consultation significantly benefits mental health patients. EHS can endorse this impact as it is being successfully utilized for our long-term mental health patients through careful selection.
In another mention-worthy project under this initiative, EHS used historical EHR data to develop a machine-learning model to rationalize and increase subscriptions to virtual visits. This AI-driven virtual visits promoter project leverages historical outpatient visits data and proactively identifies appointments that can be converted to teleconsultations, benefitting both - the patient and the environment. The machine learning model plays a crucial role in the patient selection process. EHS has employed advanced algorithms to ensure accurate identification and visualisation of the flowchart involved in the patient selection procedure. A scoring mechanism has been developed that considers several essential patient-related factors. This mechanism helps the team identify the potential demographic group and medical service candidates that can be effectively converted to virtual visits. As a result of these dedicated efforts, EHS has witnessed a spike in virtual visit subscriptions, which is reflected in our carbon emissions simulator. The team is committed to enabling high-quality care and supporting sustainable services.
EHS continues to work with our strategic partners to help ensure that the systems implemented are future-ready and sustainable for future generations. Equipped with futuristic technology and a dedicated workforce, EHS continues to contribute towards the national goal of UAE Net Zero 2050 Commitment
IN ANOTHER MENTION-WORTHY PROJECT UNDER THIS INITIATIVE, EHS USED HISTORICAL EHR DATA TO DEVELOP A MACHINELEARNING MODEL TO RATIONALIZE AND INCREASE SUBSCRIPTIONS TO VIRTUAL VISITS. THIS AI-DRIVEN VIRTUAL VISITS PROMOTER PROJECT LEVERAGES HISTORICAL OUTPATIENT VISITS DATA AND PROACTIVELY IDENTIFIES APPOINTMENTS THAT CAN BE CONVERTED TO TELECONSULTATIONS, BENEFITTING BOTHTHE PATIENT AND THE ENVIRONMENT. THE MACHINE LEARNING MODEL PLAYS A CRUCIAL ROLE IN THE PATIENT SELECTION PROCESS. .
Anxiety and stress are natural responses to various situations, fears, or triggers that everyone experiences. These feelings are normal unless they begin to interfere with daily life, potentially developing into a disorder. Research indicates that women are more prone to anxiety and stress throughout their lives, largely due to hormonal fluctuations and physiological factors. Women face numerous pressures, whether as homemakers, businesswomen, or employees, and their hormonal and emotional nature makes them more vulnerable to these challenges compared to men.
Common Causes of Stress in Women
Imaging examinations
Hormonal changes are among the most common causes of stress in women. Some experience imbalances in hormones, and lower levels of testosterone compared to men, as testosterone is responsible for feelings of happiness. Hormonal imbalances can occur before, during, and after menstruation, as well as during pregnancy, childbirth, and breastfeeding, with estrogen playing a significant role in these fluctuations.
Multiple Responsibilities
Women are often recognized for their ability to multitask. Working women juggle numerous responsibilities both at home and at work, striving not to fall short in any area. This challenge becomes even greater when children are involved.
Work Pressure
Continuous effort and pressure at work present significant challenges, contributing to persistent stress. In some jobs, women may need to work harder to prove themselves. Additionally, some women face limited career advancement, lower wages, and long working hours. Businesswomen are often racing against time to achieve success and ensure the continuity of their projects.
Misguided Beliefs
Some women adopt certain misguided beliefs
due to their environment, leading to constant anxiety and stress. Working women who bear household responsibilities without spousal support due to the false belief that they should handle these duties on their own are particularly affected by continuous pressure and stress.
Symptoms
Anxiety and stress symptoms in women can be psychological and physical. Psychological symptoms include mood swings, lack of mental clarity, severe sadness, fear, irritability, lack of concentration, sleep disturbances, and social withdrawal. Physical symptoms include rapid heartbeats, tremors, various bodily pains, stomach disorders, colon pain, acid reflux, heartburn, and difficulty breathing.
Common symptoms of general anxiety disorder and stress in women include:
• Feeling of discomfort without a direct cause.
• Lethargy, laziness, and lack of desire to perform daily tasks.
• Difficulty making decisions and inability to concentrate.
• Sleep disturbances or irregular sleep patterns.
• Muscle tension along with neck and head cramps resulting in persistent headaches.
Effects and Complications
Anxiety and stress significantly impact all body systems:
Central Nervous System
Continuous secretion of stress hormones due to chronic stress leads to nervous system disorders, manifesting as headaches, dizziness, and depression. Women are also more prone to psychological disorders like panic attacks or obsessive-compulsive disorder. Additionally, tension headaches are common symptoms often accompanying stress in women.
Cardiovascular System
Women experiencing chronic stress or anxiety are at a higher risk of cardiovascular problems due to persistently elevated
CONTINUOUS EFFORT AND PRESSURE AT WORK PRESENT SIGNIFICANT CHALLENGES, CONTRIBUTING TO PERSISTENT STRESS. IN SOME JOBS, WOMEN MAY NEED TO WORK HARDER TO PROVE THEMSELVES. ADDITIONALLY, SOME WOMEN FACE LIMITED CAREER ADVANCEMENT, LOWER WAGES, AND LONG WORKING HOURS. BUSINESSWOMEN ARE OFTEN RACING AGAINST TIME TO ACHIEVE SUCCESS AND ENSURE THE CONTINUITY OF THEIR PROJECTS.
heart rates, increased blood pressure, and prolonged exposure to cortisol, the stress hormone. Anxiety disorders can lead to heart palpitations, chest pain, and a heightened risk of hypertension and heart disease. For individuals with pre-existing heart conditions, anxiety disorders can further exacerbate the risk of complications.
Digestive System
Stress can lead to various digestive issues, including stomach pain, nausea, diarrhea, loss of appetite, and irritable bowel syndrome in some women. Conversely, others may experience weight gain due to stress-induced emotional eating, where they consume more food when feeling anxious or stressed.
Respiratory System
Anxiety and stress amplify asthma symptoms, leading to rapid breathing. If someone has chronic obstructive pulmonary disease (COPD), they may need to seek medical care to prevent complications related to anxiety.
Pregnancy
Women face numerous disorders during pregnancy due to hormonal fluctuations and health issues like vomiting and nausea. Additionally, the stress of the impending birth and the responsibility of a new baby, especially for first-time mothers, is a significant source of anxiety.
Menstrual Cycle
Hormonal changes before and during menstruation cause constant anxiety and stress, especially if the woman suffers from premenstrual syndrome (PMS), with its associated pains being a source of stress themselves.
Treatment
Generally, women are more proactive in seeking treatment for psychological disorders. They frequently visit mental health facilities in search of interventions to address their conditions or strategies for managing them. For anxiety and stress, pharmacotherapy may involve anxiolytic medications that facilitate positive cognitive patterns. However, the
cornerstone of treatment is psychotherapy, particularly aimed at implementing behavioral modifications in daily routines and promoting cognitive restructuring to replace maladaptive thoughts with positive ones, thereby achieving emotional homeostasis.
Women may undergo cognitive-behavioral therapy (CBT) depending on the severity of their anxiety. CBT involves structured sessions that assist patients in progressively resuming their pre-anxiety baseline functioning. The therapy focuses on modifying dysfunctional behaviors and cognitive distortions that contribute to anxiety, while also addressing and reforming entrenched maladaptive beliefs and schemas.
Another therapeutic approach is psychoanalytic therapy, typically indicated for chronic anxiety disorders. This long-term modality involves the therapist exploring the patient's unconscious processes to uncover the root causes of anxiety, often linked to unresolved childhood traumas. By identifying and processing these traumas, patients can alleviate the primary cognitive conflicts driving their anxiety. Additionally, clinicians advocate for adjunctive treatments such as physical exercise, which enhances neurobiological resilience, and relaxation techniques like yoga, which promote autonomic stability. Engaging in social activities, avoiding social withdrawal, prioritizing self-care, and incorporating recreational activities are also recommended to mitigate daily stressors and enhance overall psychological well-being.
STRESS CAN LEAD TO VARIOUS DIGESTIVE ISSUES, INCLUDING STOMACH PAIN, NAUSEA, DIARRHEA, LOSS OF APPETITE, AND IRRITABLE BOWEL SYNDROME IN SOME WOMEN.
Cutting-Edge Research
Renowned Speakers
Interactive Workshops
Networking Opportunities
Exhibitions
Fundoscopic
Advancing Fertility Solutions, The Role of IVF at Al-Ahli Hospital Qatar
Dr. Maysa Mohammad Khadra , Consultant Obstetrics and Gynecology, Reproductive Medicine, and IVF - Head of Department - Al-Ahli Hospital / Qatar
In recent years, Qatar has witnessed a significant increase in the demand for In Vitro Fertilization (IVF) services due to rising infertility rates. Amidst this growing need, Al-Ahli Hospital Qatar has emerged as a leading center for IVF treatment, offering hope and success to countless couples struggling with infertility. This article explores the IVF landscape in Qatar and highlights why Al-Ahli Hospital's IVF center stands out as a beacon of hope for couples seeking fertility solutions.
The IVF Landscape in Qatar
Infertility affects a considerable number of couples in Qatar, with various factors contributing
to this challenge. Changes in lifestyle, delayed childbearing, and medical conditions such as polycystic ovary syndrome (PCOS) and endometriosis are among the primary causes of infertility in the region. In response to this growing issue, the demand for IVF treatment has surged, prompting the establishment of specialized fertility centers across the country.
Why Choose Al- Ahli Hospital Qatar IVF Center?
Al-Ahli Hospital Qatar IVF Center distinguishes itself as a premier destination for couples seeking IVF treatment. Here are several reasons why:
AL-AHLI HOSPITAL QATAR IVF CENTER DISTINGUISHES ITSELF AS A PREMIER DESTINATION FOR COUPLES SEEKING IVF TREATMENT.
Cutting-Edge Technology: Al-Ahli Hospital Qatar is equipped with state-of-the-art facilities and the latest advancements in reproductive technology. From advanced embryo selection techniques to comprehensive genetic screening, the IVF center utilizes cutting-edge technology to maximize success rates and ensure the highest standard of care for patients.
Experienced Specialists: The IVF center at Al-Ahli Hospital boasts a team of highly skilled and experienced fertility specialists, including reproductive endocrinologists, embryologists, and nurses. These experts collaborate closely to develop personalized treatment plans tailored to each couple's unique needs, ensuring optimal outcomes and patient satisfaction.
Comprehensive Services: Al-Ahli Hospital Qatar IVF Center offers a comprehensive range of fertility services, including in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), preimplantation genetic testing (PGT), and egg freezing. The center also provides support services such as counseling, nutritional guidance, and stress management, addressing the holistic needs of patients throughout their fertility journey.
Success Stories: One of the hallmarks of
Al -Ahli Hospital Qatar IVF Center is its track record of success stories. Countless couples have achieved their dream of parenthood through the center's innovative treatments and compassionate care. These success stories serve as a testament to the expertise and dedication of the medical team at Al -Ahli Hospital, instilling confidence in prospective patients and reaffirming the center's reputation as a trusted leader in fertility care.
Conclusion
Al- Ahli Hospital Qatar IVF Center plays a pivotal role in addressing the growing demand for fertility services in Qatar. With its commitment to excellence, cutting-edge technology, and personalized approach to care, the center offers hope and support to couples struggling with infertility. By choosing Al -Ahli Hospital Qatar IVF Center, couples can embark on their journey to parenthood with confidence, knowing that they are in capable hands.
IN RECENT YEARS, QATAR HAS WITNESSED A SIGNIFICANT INCREASE IN THE DEMAND FOR IN VITRO FERTILIZATION (IVF) SERVICES DUE TO RISING INFERTILITY RATES. AMIDST THIS GROWING NEED, AL-AHLI HOSPITAL QATAR HAS EMERGED AS A LEADING CENTER FOR IVF TREATMENT, OFFERING HOPE AND SUCCESS TO COUNTLESS COUPLES STRUGGLING WITH INFERTILITY.
Confronting Depression: A Journey Towards Restoring Hope and Mental Health
Depression significantly impacts mental health by causing persistent feelings of sadness, emptiness, and a loss of joy and the ability to experience pleasure. These feelings often seem to arise without any clear reason. As a mood disorder, depression affects how individuals feel, think, act, and perceive the world around them. It can undermine relationships and make maintaining a healthy lifestyle challenging. In severe cases, it can lead to suicide. Depression is a common and serious psychological disorder affecting adults, teenagers, and children alike, differing from normal mood fluctuations. It is a persistent and chronic condition that negatively impacts a person even when external circumstances improve.
Causes of Depression
Depression results from a combination of biological factors, including brain structure and chemistry, hormonal imbalances, genetic predispositions, and certain medical conditions. These factors interact to produce and sustain symptoms of depression. No single medical cause is identified; research indicates that depression arises from a complex interaction between genetic and environmental factors.
1. Genetic Factors: Genetics play a significant role in determining an individual's susceptibility to depression. A family history of depression increases the risk for other family members.
2. Environmental Factors: These influence how genes are expressed and include stressful events such as job loss, death, divorce, physical or emotional abuse, and certain physical illnesses like heart disease or cancer.
The interplay of genetic and environmental factors leads to the onset of depression. For instance, a genetically predisposed individual may not develop depression unless exposed to a stressful life event.
Impact of Depression on a Patient's Life
Quality of Life
Depression causes a persistent feeling of sadness and emptiness, even when there are reasons to be content. It can lead to a sense of helplessness and loss of hope for the future, social isolation, and a reduced desire to interact with friends and family or participate in social activities. People with depression often feel irritable and fatigued, even during activities they usually enjoy.
Depression is often accompanied by constant anxiety and tension, affecting the ability to relax and enjoy life. Those affected may struggle with concentration and clear thinking due to mental distraction. They also suffer from a lack of energy and severe fatigue, even after simple tasks, which can be coupled with difficulty sleeping or excessive sleepiness.
Emotional Changes
Depression leads to prolonged feelings of sadness, emptiness, hopelessness, and irritability. Negative thoughts about oneself and the future dominate, and the individual becomes unable to feel happiness or satisfaction even in situations previously enjoyed. The patient may become isolated from family and friends, preferring solitude and avoiding social activities due to discomfort or lack of interest. There is often a neglect of personal appearance and hygiene.
Cognitive Function
Depression can impair concentration, memory, decision-making, and problem-solving abilities, making it difficult to focus on tasks and complete them efficiently. Patients may find it hard to stay attentive, remember information, or retrieve memories. Over time, they struggle with decision-making, experiencing hesitation and confusion even with simple choices, and their ability to find effective solutions to daily problems diminishes.
Social Withdrawal
Individuals with depression may isolate themselves from social interactions, leading to feelings of loneliness, disconnection, and a lack of interest in maintaining relationships. Depression often results in social withdrawal from family and friends, avoiding social activities, and losing interest in maintaining relationships. This behavior leads to a deep sense of loneliness and separation from others, further exacerbating social isolation and deteriorating relationships with family and friends.
Impact on Work or Study
Depression can affect work performance, productivity, attendance, and motivation, making it difficult to meet responsibilities and goals in work or academic settings. It can cause a decline in the ability to concentrate and stay attentive, leading to difficulties in completing tasks effectively and decreased productivity. Severe cases of depression make it hard to attend work or school regularly, leading to
SEVERE CASES OF DEPRESSION MAKE IT HARD TO ATTEND WORK OR SCHOOL REGULARLY, LEADING TO FREQUENT TARDINESS OR ABSENTEEISM, WHICH AFFECTS PROGRESS AND COMMITMENT TO TASKS AND DEADLINES. OVER TIME, ENTHUSIASM AND INTEREST IN WORK OR STUDIES WANE, AFFECTING COLLABORATION WITH COLLEAGUES OR COMMUNICATION WITH CLASSMATES AND IMPACTING THE SOCIAL AND WORK ENVIRONMENT
frequent tardiness or absenteeism, which affects progress and commitment to tasks and deadlines. Over time, enthusiasm and interest in work or studies wane, affecting collaboration with colleagues or communication with classmates and impacting the social and work environment.
Physical Symptoms
Although depression is a psychological disorder, it can also have physical effects. Common physical symptoms in people with depression include:
• Fatigue and Exhaustion: Constant tiredness and fatigue even after minor efforts, making it hard to regain energy and vitality.
• Sleep Disorders: Depression can cause sleep problems such as insomnia and frequent waking during the night, or the opposite, excessive sleep.
• Changes in Appetite and Weight: Depression can lead to changes in appetite and weight, with some experiencing loss of appetite and weight loss, while others experience increased appetite and weight gain.
• Body Pain: Individuals with depression may suffer from unexplained body pain, such as headaches, muscle aches, and joint pain. These pains can be persistent or accompany mood declines.
• Digestive Disorders: Depression can affect the digestive system, causing issues like nausea, vomiting, constipation, or diarrhea.
• Cardiovascular and Respiratory Disorders: People with depression may experience increased heart rate, chest pain, difficulty breathing, and dizziness.
Treatment Mechanisms
The choice of treatment depends on the severity of depression and individual preferences. A combination of psychotherapy and medication is often recommended, especially for moderate to severe depression.
Medication
Antidepressants are medications that
can help regulate brain chemicals involved in mood regulation. It is important to note that antidepressants may take several weeks to start working and can have side effects. These side effects should be discussed with a doctor to determine if the medication is appropriate based on the patient's condition and its progression.
Psychotherapy (Talk Therapy)
This type of therapy involves talking to a qualified mental health professional. Different types of psychotherapy can be effective for depression, such as:
Cognitive Behavioral Therapy (CBT)
Helps identify and change negative thinking patterns that contribute to depression. CBT assists patients in replacing negative thoughts with more realistic and positive ones. Patients learn to analyze and confront negative thoughts, identifying and balancing distorted thoughts that affect their mood and reinforce depression. They also learn to recognize harmful behaviors and replace them with positive, healthy ones to improve mood and social interactions. CBT helps patients develop positive beliefs, self-esteem, optimism, and mental resilience.
Interpersonal Therapy (IPT)
Focuses on improving the patient's relationships with their environment, including family, friends, and colleagues. Enhancing relationships can alleviate depression symptoms and promote overall mental health. Family and social support provide emotional encouragement, helping patients feel secure and comfortable when they have a close person who understands their suffering. IPT aims to improve communication skills, manage conflicts, and expand social support networks, reducing isolation and loneliness.
In IPT, patients learn to understand and address interpersonal conflicts and stress patterns in relationships, learning problemsolving and negotiation strategies, and fostering empathy. IPT also teaches patients social skills to build supportive relationships, recognize and respect others' feelings, and improve social interactions.
DEPRESSION
IS A COMMON AND SERIOUS PSYCHOLOGICAL DISORDER AFFECTING ADULTS, TEENAGERS, AND CHILDREN ALIKE, DIFFERING FROM NORMAL MOOD FLUCTUATIONS. IT IS A PERSISTENT AND CHRONIC CONDITION THAT NEGATIVELY IMPACTS A PERSON EVEN WHEN EXTERNAL CIRCUMSTANCES IMPROVE.
Aligament is a strong band of tissues that connects two bones. The Anterior Cruciate Ligament (ACL) connects the thigh bone (femur) to the shin bone (tibia). It stabilizes the knee in more than one place and direction.
Injury to this ligament happens when the person stops suddenly or when he jumps and lands on a foot that gets firmly fixed to the ground and the rest of the body twists, or when the player is tackled by someone else. It happens usually in football, basketball or skiing. The injured person usually hears a pop and will feel pain bad enough to stop him from continuing the activity he was doing, and the knee will swell up within one hour. In chronic injuries, the main complaint will be that the knee gives way and is unstable especially when changing direction suddenly while walking.
Causes
Ligaments are strong bands of tissue that connect one bone to another. The ACL, one of two ligaments that cross in the middle of the knee, connects your thighbone to your shinbone and helps stabilize your knee joint.
ACL injuries often happen during sports and fitness activities that can put stress on the knee:
• Suddenly slowing down and changing direction (cutting)
• Pivoting with your foot firmly planted
• Landing awkwardly from a jump
• Stopping suddenly
• Receiving a direct blow to the knee or having a collision, such as a football tackle
• When the ligament is damaged, there is usually a partial or complete tear of the tissue. A mild injury may stretch the ligament but leave it intact.
Risk factors
There are a number of factors that increase your risk of an ACL injury, including:
• Being female — possibly due to differences in anatomy, muscle strength and hormonal influences
• Participating in certain sports, such as soccer, football, basketball, gymnastics and downhill skiing
• Poor conditioning
• Using faulty movement patterns, such as moving the knees inward during a squat
• Wearing footwear that doesn't fit properly
• Using poorly maintained sports equipment, such as ski bindings that aren't adjusted properly
• Playing on artificial turf
TRAINING TO STRENGTHEN MUSCLES OF THE LEGS, HIPS AND CORE — AS WELL AS TRAINING TO IMPROVE JUMPING AND LANDING TECHNIQUES AND TO PREVENT INWARD MOVEMENT OF THE KNEE — MAY HELP TO REDUCE THE HIGHER ACL INJURY RISK IN FEMALE ATHLETES.
Prevention
Proper training and exercise can help reduce the risk of ACL injury. A sports medicine physician, physical therapist, athletic trainer or other specialist in sports medicine can provide assessment, instruction and feedback that can help you reduce risks.
Programs to reduce ACL injury include:
• Exercises to strengthen the core — including the hips, pelvis and lower abdomen — with a goal of training athletes to avoid moving the knee inward during a squat
• Exercises that strengthen leg muscles, particularly hamstring exercises, to ensure an overall balance in leg muscle strength
• Training and exercise emphasizing proper technique and knee position when jumping and landing from jumps
• Training to improve technique when performing pivoting and cutting movements
• Training to strengthen muscles of the legs, hips and core — as well as training to improve jumping and landing techniques and to prevent inward movement of the knee — may help to reduce the higher ACL injury risk in female athletes.
Gear
Wear footwear and padding that is appropriate for your sport to help prevent injury. If you downhill ski, make sure your ski bindings are adjusted correctly by a trained professional so that your skis will release appropriately if you fall.
Wearing a knee brace doesn't appear to prevent ACL injury or reduce the risk of recurring injury after surgery.
Depending on the nature and the severity of the injury, the treatment will be decided. For bruised ACL without significant stretch or damage, conservative treatment will be used to strengthen the muscles and help the
patient recover. If the ACL is completely torn, or badly stretched to a degree which renders it dysfunctional, or if there is another injured ligament or meniscus, then surgery is used to replace the torn ACL. A significant number of patients will have other injuries with the cruciate ligament like meniscal injury, other ligament injury, or covering cartilage injury.
Patients with torn / dysfunctional ACLs will experience instability of the knee when twisting or pivoting the knee. They also stand a much higher chance of developing wear and tear arthritis in the knee at a much younger age. For these reasons surgery is advised in those patients, first to enable them to live a normal life and be able to participate in sports, and to protect the knee from early arthritis which will require knee replacement surgery at a younger age.
The diagnosis of this condition starts with taking a full detailed history from the patient, followed by a thorough examination. X-ray is used to exclude fractures and ultrasound can help in diagnosis but MRI remains the gold standard in diagnosing ACL injury.
Surgery is done through keyhole (arthroscopic) operation. The remnant of the torn ligament is removed and replaced with a graft. The replacement ligament (graft) can be taken from the patient's tissues / tendons (autograft), or from a dead donor (allograft), or an artificial graft can be used. Studies have shown that patient's own tisses (autografts) are the best. Artificial grafts have recently been abandoned for their bad results. If any concomitant injury was found during the surgery, it will be dealt with at the same time.
After surgery, vigorous rehabilitation is required to go back to normal level of activities. It takes on average nine months to go back to contact sports, like football, basketball and rugby.
PATIENTS WITH TORN / DYSFUNCTIONAL ACLS WILL EXPERIENCE INSTABILITY OF THE KNEE WHEN TWISTING OR PIVOTING THE KNEE. THEY ALSO STAND A MUCH HIGHER CHANCE OF DEVELOPING WEAR AND TEAR ARTHRITIS IN THE KNEE AT A MUCH YOUNGER AGE. FOR THESE REASONS SURGERY IS ADVISED IN THOSE PATIENTS, FIRST TO ENABLE THEM TO LIVE A NORMAL LIFE AND BE ABLE TO PARTICIPATE IN SPORTS, AND TO PROTECT THE KNEE FROM EARLY ARTHRITIS WHICH WILL REQUIRE KNEE REPLACEMENT SURGERY AT A YOUNGER AGE.
Geneva to host the International Hospital Federation (IHF) World Hospital Congress in 2025
The International Hospital Federation (IHF) has announced that the 48th World Hospital Congress will be held in Geneva, Switzerland, in November 2025 with the University Hospital of Geneva (HUG) and the Canton serving as host. The Congress brings together hospital leaders and healthcare system executives to connect around global learning for local action while attracting around 1500 participants each year from more than 90 countries.
The IHF will collaborate with the University Hospital of Geneva (HUG) and the Canton of Geneva to host the annual event at the International Conference Centre of Geneva (CICG) from 10 to 13 November 2025. This marks the first time in history that the event is being held in Geneva and a significant occasion for the IHF as the city is also home to its headquarters. Switzerland has hosted two previous editions of the congress; in Lucerne in 1955, and in Lausanne in 1983.
Following on from the selection of the
host organization, representatives of the HUG will join the organizing committee of the 2025 edition of this event.
The Congress brings together hospital leaders and healthcare system executives to connect around global learning for local action.
The IHF is the only organization that provides a global forum specifically for leaders and executives to build capacity and foster good practice in the management of healthcare delivery.
Improving the standard, quality, and level of service delivery
The HUG is a stand-alone associate member of the IHF and a long-standing supporter of its mission to promote leadership development, knowledge exchange, and advocacy to improve the standard, quality, and level of service delivery in hospitals and healthcare settings. In addition to holding a seat on the IHF’s Governing Council, the HUG supported the IHF to establish the Geneva Sustainability Centre. The centre provides a global platform for hospitals to evolve
THE HUG IS A STAND-ALONE ASSOCIATE MEMBER OF THE IHF AND A LONG-STANDING SUPPORTER OF ITS MISSION TO PROMOTE LEADERSHIP DEVELOPMENT, KNOWLEDGE EXCHANGE, AND ADVOCACY TO IMPROVE THE STANDARD, QUALITY, AND LEVEL OF SERVICE DELIVERY IN HOSPITALS AND HEALTHCARE SETTINGS. IN ADDITION TO HOLDING A SEAT ON THE IHF’S GOVERNING COUNCIL, THE HUG SUPPORTED THE IHF TO ESTABLISH THE GENEVA SUSTAINABILITY CENTRE.
as leaders for sustainability in their communities. The HUG has also provided the IHF with office space for its headquarters since 2011.
Ronald Lavater, CEO of the IHF, explained the NGO’s strong ties to Geneva: “It’s a great honor to be able to bring our World Hospital Congress to Geneva for the first time. This could not have been possible without the support of the outgoing Director General of HUG and board member of the IHF, Bertrand Levrat. Bertrand championed our proposal and gained strong support from the HUG, the Canton of Geneva, and Geneva Convention Bureau, which made it possible. The HUG is an active member within H+ Swiss Hospitals, the IHF’s full national member. We look forward to working with all of these Swiss organizations to bring to our home city an outstanding World Hospital Congress.”
Alain Kolly, HUG Acting Director General, declared: “The HUG is deeply honored to be hosting its fellow pioneering healthcare institutions, from the IHF family and beyond. The 2025 IHF Congress will allow participants to discover not only our local expertise but also the synergies we have developed, both locally and internationally.”
Alain-Dominique Mauris, President of the HUG Executive board added: “The University Hospital of Geneva has a legacy of nurturing networks and collaborations. Its deep commitment to global knowledge exchange and sustainability in the healthcare sector underpins our vision for the organization of this event with IHF and our national partners.”
Geneva Minister for Health and Mobility, Pierre Maudet observed: “Geneva is home to over 40 international organizations and 400 NGOs and its ability to forge impactful partnerships on a global scale is renowned. Geneva is excited to welcome the IHF Congress and thus contribute to further advancing shared global goals in healthcare."
The IHF’s Geneva Sustainability
Centre will influence the program
The Congress attracts around 1500 participants each year from more than 90 countries. An announcement about the scientific tracks and abstract submissions for the 2025 Congress will be made in November 2024. The program will include a stimulating array of plenary and parallel sessions, pre-congress masterclasses, invitational forums, workshops, networking opportunities, local hospital visits, and poster presentations.
Participants can also look forward to booking a seat at the IHF Awards Ceremony and Gala Dinner – a celebration to recognize outstanding hospital projects, programs, and services on a global stage.
Sustainability will be integral to the organization and delivery of the 48th World Hospital Congress. The IHF’s Geneva Sustainability Centre, which supports hospital and healthcare executives leading the transformation to low carbon, resilient, and sustainable healthcare, will influence the programs as one of the core tracks designed by the scientific committee. The organizing committee will also prioritize delivering an environmentally sustainable Congress, which can act as an example to participants for ways to reduce the carbon footprint of events, as well as providing a positive experience to visitors and preserving the local environment for its community.
From innovation to implementation
Innovation will also be a key focus at the 48th edition, with the return of the IHF’s i-to-i Innovation Hub – from innovation to implementation – which was first introduced at the Congress in 2023. The Hub showcases cutting-edge innovations that can demonstrate their impact in transforming hospital and healthcare-delivery settings. The Hub will have a bespoke space at the Congress venue, promoting collaboration, and enabling participants to engage directly with the featured innovators.
THE CONGRESS BRINGS TOGETHER HOSPITAL LEADERS AND HEALTHCARE SYSTEM EXECUTIVES TO CONNECT AROUND GLOBAL LEARNING FOR LOCAL ACTION. THE IHF IS THE ONLY ORGANIZATION THAT PROVIDES A GLOBAL FORUM SPECIFICALLY FOR LEADERS AND EXECUTIVES TO BUILD CAPACITY AND FOSTER GOOD PRACTICE IN THE MANAGEMENT OF HEALTHCARE DELIVERY.
Healthcare, politics, and public policies
Dr. Ali Elhaj, CEO, Ardens Health Chair, Governance, Leadership and Research Division Arab Hospital Federation
The relationship between healthcare and politics and the ills therein transcends the globe; Health and healthcare are fundamentally about relationships—between individuals and health professionals, between patients and their symptoms, between cultural beliefs and professionals, between community groups or organizations and the health system, between people and their governments and public institutions, and so on. Hence, the reason why the connection between healthcare and politics is rational, public policy and governmental activism both perpetuate and alleviate global inequalities and inequities in well-being.
Health is often described most simply as "absence of disease" and more broadly, as "a state of complete physical, mental, and social well-being." The political coverage of health is equally broad: it is not just about the delivery and funding of clinical care but also about how health is created, maintained, and if lost, restored. Thus, political coverage of health includes public health issues, such as water and air pollution and sanitation. As part of this broad coverage of health, those who deliver the service, whether practitioners or institutions, are political participants. They see themselves as stakeholders, or as victims when policies or targets have an effect on their legitimately acquired interests.
While most of the traditional norms in many countries
focus on the ethics of healthcare and the public role in providing care, research, and access to healthcare services, public choice theory presents an economic analysis of political decision-making. The public choice theory offers an alternative lens from which to consider and enact public policies, as well as understanding decisions made in the healthcare industry. Policy decisions in healthcare are not health-related decisions; rather, decisions made are through representatives or groups elected and subject to political constraints. Politics can often engage issues of scarcity, special interests, and personal freedom, resulting in financial constraints.
Governments have control over power and funding; citizens have the ability to participate, share their knowledge, and pressurize governments to deal with their concerns or affect the policies that they need. Although financial and resources may vary, enabling mechanisms for groups within all societies to secure political voice do exist potentially. Proponents of health as a human right tend to focus primarily on voice within political systems. It seems important then to expand current concepts of political voice to account for additional political factors that shape power relations in ever-increasing politically securitized governance arenas that currently influence questions of health.
All countries currently face the challenges of reorganizing, restructuring, or redesigning their healthcare systems. Health (care) is globally universal in that everyone gets ill at some point in time. It refers to a consuming good or service (care) and it deals with the most precious 'commodity' one can have: life. The nature of age, the gravity of the illness, the capacity to pay, the knowledge of contemporary standards of treatment, and the nature of healthcare systems (including what is funded from collective funds) differ considerably from one country to the other, depending on historical, economic, social, political, and cultural patterns. In all contexts, different societies, different healthcare systems, and different politicians face the ongoing challenge of balancing solidarity and subsidiarity and of trying to find innovative solutions concerning the question of 'who pays' and 'how much' in what way and toward which purpose. In essence, they try to answer the question as to what extent the private and the public sectors should control resources, should take care of patients, and should be involved in the process of treatment and care.
HYBRIMATT
Active and passive mattress in one
Microclimate maintenance helps with thermoregulation by air flow and a permeable cover.
The 2-cell alternating therapy system of HybriMatt provides periodic pressure reduction.
Viscoelastic foam reacts to body heat and body weight.
The heel section has a 7-degree slope that reduces pressure in this high-risk area.
